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ABSTRACT OF THE DISSERTATION
Effects of Spaceflight on Phagocytic Function and
Immune-Neural Interaction
by
Farnaz P. Baqai
Doctor of Philosophy, Graduate program in Biochemistry
Loma Linda University, June 2009
Dr. Michael J. Pecaut, Chairperson

In spaceflight, astronauts will be exposed to several environmental risk
factors that may lead to disturbances in homeostasis maintained by the central
nervous system (CNS) and immune system. Low Earth orbit (LEO) spaceflight
studies have shown that microgravity changes virtually all immune parameters
that have been evaluated. Similarly, ground based studies have shown that lowdose radiation can also significantly impact immune function. Finally, as most
spacecrafts are ecologically and environmentally closed systems, astronauts
may be at increased risk for exposure to aerosolized infectious agents. The
hypothesis of this study is: Exposure to spaceflight environment (microgravity
and radiation) can influence immune responses by upregulation of innate
immune responses, altering cytokine expression and ultimately influencing CNSimmune communication.
To elucidate the effects of the inertial aspects of the spaceflight
environment on ex vivo inflammatory responses in mice flown on the Space
Shuttle Endeavour for 13 days, we characterized several parameters including
lymphoid organ masses, splenic leukocyte population distributions, in vitro
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cytokine secretion patterns and proliferative response to a B cell mitogen, and
reactive oxygen species (ROS) scavenging gene expression. We next
investigated the effects of low-dose radiation on the response to a live pathogen.
Mice were exposed to 3 Gray (Gy) whole-body proton radiation and were
inoculated with Escherichia coli (E. coli). Changes in leukocyte populations,
cytokine secretions, phagocytic activity, bacteria clearance, Major
histocompatibility complex class II (MHC II) expression and cFos in the
paraventriculuar nucleus (PVN) were characterized. We then examined the
effects of body-only proton radiation exposure on phagocytic activity to determine
the role played by immune-CNS communication in radiation-induced changes
using a series of assays similar to those used in the whole-body radiation study.
Depression in leukocyte populations and changes in cytokine secretion
patterns were noted after exposure to each environmental factor. Our findings
also demonstrate an increase in innate immune response, reduced signaling
from periphery to CNS and increase in ROS levels. Collectively, our data suggest
that spaceflight related stressors can pose a serious health risk to astronauts.
These changes could potentially inhibit the adaptive immune response to
pathogens, compromising appropriate mechanisms of pathogen clearance.
Increases in inflammatory responses, if prolonged can potentially lead to tissue
damage and cause chronic inflammatory diseases.

xx

CHAPTER ONE
INTRODUCTION
Overview of Spaceflight
Space agencies around the world have begun to refocus their programs
towards exploration, including colonization of the moon and Mars. Astronauts on
long duration missions will be exposed to several environmental risk factors,
which may have dramatic effects on health. These risk factors include isolation,
nutrition, changes in circadian rhythm, microgravity, and long-term exposure to
low-dose radiation (Hellweg and Baumstark-Khan 2007; Kauret al. 2005;
Sonnenfeld 2005). Space shuttle experiments, as well as ground-based spacesimulation studies (e.g. centrifugation or anti-orthostatic tail suspension) have
shown that the inertial aspects of the spaceflight environment can influence
several physiological systems potentially resulting in serious consequences for
effective immune defense. Research has also shown that moderate levels of
whole-body radiation exposure can have significant effects on immunity.

Brief Overview of the Spaceflight Environment
Microgravity
Research has revealed the importance of gravity for the proper functioning
of living systems (Ullrich, Huber, and Lang 2008). Changes in the gravitational
environment necessitates specific physiological adaptations in astronauts which
may have long-term consequences even after the return to Earth, and manifest
1

themselves as physical impairments. These changes include loss of fluid
electrolytes, cephalad fluid shifts (Hughes-Fulford 1991; McCarthy 2005), loss of
muscle mass (McCarthy 2005) and bone (Tamma et al. 2009), reduction in
plasma and blood volume (McCarthy 2005), cardiovascular atrophy (Berkowitz
2007) and changes in the immune system (Durnova, Kaplansky, and Portugalov
1976; Sonnenfeld et al. 1998).

Radiation
On Earth, humans are protected from radiation by the Earth’s atmosphere
and geomagnetic field. The Earth’s atmosphere shields the Earth from radiation
by process of scattering, which results in redirecting a significant proportion of
solar radiation back to space. Absorption and reflection of radiation by the
atmosphere also reduces the amount of radiation received on Earth. The Earth’s
geomagnetic field also traps charged particles (electrons and protons) in Van
Allen radiation Belts, further reducing the amount of radiation received on Earth.
As astronauts venture on missions beyond low Earth orbit (LEO) and the Van
Allen Belts, they will be exposed to transient, relatively high doses of radiation
from solar particle events (SPEs), as well as continuous low-dose/low-dose-rate
radiation from high-energy galactic cosmic rays (OCRs) (Fig. 1). Hence
exposure to ionizing radiation is an unavoidable consequence of long-term
spaceflight missions. Indeed, while in transit to and from Mars, current mission
models estimate that exposure doses will be approximately 0.7 Sieved (Sv)
(Hoffman 1997; Setlow 1996).

2

Figure 1. Sources of space radiation
(Townsend 2007)
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Radiation from GCRs originates from outside our solar system and
consists of 98% baryons (high energy/high linear energy transfer, or LET, nuclei)
and 2% electrons. The Baryonic component is composed of -87% protons,
-12% alpha particles and -1% heavier nuclei with atomic numbers up to 92
(uranium). The energy range of GCRs extends over 15 orders of magnitude from
less than 1MeV to more than 1015eV (Hellweg and Baumstark-Khan 2007).
SPEs consist primarily of 90% protons, high energy particles (HZE ions)
and alpha particles, with a heavy ion component, originating from the coronal
mass eruptions on the Sun (Townsend 2005). The source region is believed to
be near active regions on the Sun’s surface. Events appear to be more frequent
near solar maximum and a single active region may produce several SPEs over
a period of weeks. Although the frequency of events appears to coincide with the
11-year solar cycle, the occurrence of individual SPEs are more or less random
making it very difficult to predict the appearance and magnitude of these events
(Xapsos et al. 2006). Based on data obtained from the August 1972 coronal
mass eruption, it was estimated that astronauts would have been exposed to a
skin absorbed dose of 15.01 Gray (Gy) (28.24 Sv) and a bone marrow absorbed
dose of 0.79 Gy (1.11 Sv), with an overall effective dose of 3.38 Sv (Townsend
2007).
The effects of ionizing radiation on human beings are categorized as
either acute or delayed. Some of the acute effects include nausea, fluid loss, and
hemorrhage. The delayed effects include gastrointestinal and hematopoietic
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syndromes, leading to a decreased resistance against infections and an
increased cancer incidence (Hellweg and Baumstark-Khan 2007).

Infectious Agents and Spaceflight
As most spacecraft are ecologically and environmentally closed systems,
astronauts may be exposed to aerosolized pathogens. Microorganisms, which
present a threat of infection during long-term space voyages, include Gram
negative intestinal conforms such as Klebsiella Enterobacter, and Escherichia
coll (E. coli) as well as the ubiquitous bacteria, Pseudomonus aeruginosa all of
which have lipopolysaccharide (LPS) in their cell wall. These bacteria result in
highly common nosocomial infections, which often lead to septicemia. Prior to the
institution of pre-flight quarantine, several in-flight infections such as cutaneous
abscesses, sties (secondary to Staphylococcus aureus) and Pseudomonas
urinary tract infection were reported (Meehan, Whitson, and Sams 1993). Even
with pre-flight quarantine conditions, it may be difficult to avoid exposure to
pathogenic agents during the missions due to potential failure in waste handling
equipment and decontamination systems (Sonnenfeld 2001a), as well as
crowded living-conditions aboard the space craft. In addition, studies have shown
that response to antibiotics against infections may be less than optimal due to
microgravity (Klaus and Howard 2006; Taylor and Sommer 2005). The cellular
and molecular components of the innate immune system provide the first line of
defense against pathogens. It is therefore essential for astronauts to maintain a
healthy immune system.

5

Brief Overview of the Immune System
The immune system is an organization of cells and molecules with
specialized roles in defense against infection. Defense reactions are divided into
innate (nonspecific) and acquired (adaptive, specific) immune responses. Innate
immunity is the first line of defense against infection. Innate responses involve
phagocytic cells (monocytes, neutrophils and macrophages), cells that release
inflammatory mediators (mast cells and basophils) and natural killer (NK) cells.
During the innate immune response, pathogens are processed and acute phase
proteins and cytokines are released. Should the infection persist, adaptive
immune responses moderated by T lymphocytes are activated. The activity of T
cells is subdivided into T helper 1 (Th1) and T helper 2 (Th2) pathways, each
directing a different immune response. Th1 cells drive cell-mediated immunity,
including macrophage activation and T cell-mediated cytotoxicity, which are
primarily responsible for fighting off viruses, detecting cancerous cells, and
eliminating intracellular pathogens (Kidd 2003; Mackay and Rosen 2000a). Th2
response activates B cells and produces antibodies specific for extracellular
pathogens (Goldsby et al. Immunolgy 2003). The balance between these two
responses is determined by the type of infection (e.g. viral vs. bacterial) and is
maintained mainly by cytokines. In a healthy individual, both the innate and
acquired responses work together to eliminate the vast majority of potential
pathogens.

6

Adaptive immune responses are often initiated in the lymph nodes, spleen
and mucosa associated lymphoid tissue (Mackay and Rosen 2000b). The focus
of this study is mainly on the activity of macrophages in the spleen.

Monocytes and Macrophages
Monocytes are mononuclear phagocytic cells that develop in the bone
marrow and enter the blood. In humans, monocytes typically circulate in the
bloodstream for approximately 8 hours until they enlarge and enter various
tissues as macrophages, infiltrating all lymphoid and non-lymphoid organs. Once
activated, macrophages are able to phagocytose pathogens, produce ROS,
hydrolytic enzymes and other soluble factors such as cytokines. While many
macrophages remain motile, many also are able to reside in particular tissues
becoming fixed macrophages. Macrophage-like cells are named according to
their tissue location: alveolar macrophages in the lung, histiocytes in connective
tissue, Kupffer cells in the liver, mesangial cells in the kidney, microglial cells in
the brain and osteoclasts in the bone (Goldsby et al. Immunlogy 2003;
Schedlowski and Tewes 1999).

Spleen
The spleen, situated in the left upper abdomen, plays a major role in
mounting an immune response to antigens in the blood. This organ is formed by
reticular fibers and cells, and has two distinct portions (Fig. 2). Seventy-five
percent of the spleen is red by gross examination in cross-sectional cuts, and is
termed the red pulp. This consists of sinusoids populated by macrophages, many
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red blood cells and very few lymphocytes. Interspersed in the red pulp are white
nodules, referred to as the white pulp. The white pulp is subdivided into a
periarterial lymphatic sheath (PALS), which surrounds the central arteriole and is
populated mainly by T lymphocytes, and the follicles, which contain mainly B
lymphocytes. The white pulp is separated from the red pulp by the marginal
zone, which is populated by B lymphocytes and macrophages are present in all
compartments of the spleen (Goldsby et al. Immunolgy 2003] Suttie 2006).
The spleen has an excellent blood supply and receives approximately 4%
of the entire blood flow of the body at any time. Blood flow is regulated at the
marginal zone, directed through the marginal zone and the red pulp through slits
between endothelial cells which act in a sieve-like system of phagocytosing cells
(Schedlowski and Tewes 1999) allowing the spleen to filter the blood. This
facilitates the removal of old erythrocytes and pathogens. Initial activation of B
and T cells occurs in the PALS, where dendritic cells phagocytose antigens and
present them to Th cells via major MHC II molecules. Activated B cells then
migrate to primary follicles in the marginal zone, which develop into secondary
follicles. The majority of lymphocytes exit the spleen via the blood (Cesta 2006;
Goldsby et al. Immunlogy 2003] Schedlowski and Tewes 1999).
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(immuneweb.xxmu.edu.cn)
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Innate Immune Response
In a healthy individual, foreign pathogens (e.g. LPS) are typically cleared
from the body within a few hours. The cells that take part in this process are
primarily neutrophils, NK cells, eosinophils and macrophages. Macrophages are
the most efficient phagocytes and are found in all body tissues (Male et al. 2006).
They are able to detect infectious organisms via a plethora of receptors
phagocytose them, and coordinate an appropriate response.

Pathogen Recognition
Macrophages posses pathogen recognition receptors, or PRRs, which are
able to recognize specific pathogen associated molecular patterns or PAMPs.
There are several PRR mediated phagocytic pathways, which include
crystallizable fragment (Fc), complement, and scavenger receptors (SR), lectins
and integrins. Macrophages express different combinations of Fc gamma
receptors (FcyRs), which recognize immunoglobulin G (IgG) -opsonized bacteria.
These form a complex and the opsonized bacteria are then phagocytosed.
Activation of inflammatory responses is regulated by additional receptors, which
are able to recognize the pathogen. Lipid A, the toxic component of LPS is a
well-conserved molecule and hence macrophages posses specific PRRs for
LPS. LPS forms a complex with lipid binding protein (LBP), which is then
transferred to CD14, a glycosylphosphatidylinositol-linked cell surface
glycoprotein (Pinner et al. 1996) expressed on macrophages. This complex can
then bind to MD-2, an adaptor molecule, which links the LPS/LBP complex to a
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specific PRR, such as toll-like receptor 4 (TLR4). The engagement of IPS by this
complex causes its TLR component to initiate signal transduction by activating
proximal components MyD88, interleukin-1 (IL-1) receptor-associated kinase,
tumor necrosis factor receptor-associated factor-6, and nuclear factor kappa B
(NF-kB) inducing kinase of the IL-1 signaling pathway that lead to NF-kB
activation (Chow et al. 1999), involved in activation of inflammatory cytokine
genes.

Phagocytosis
Phagocytosis is one of the most important aspects of the innate immune
response, and is one of the first steps in initiating host defense and inflammation.
Phagocyte-microbe contact is accompanied by a series of intracellular signals,
including changes in membrane trafficking, activation of pathogen destruction
mechanisms, and production of cytokines (Chow et al. 1999; Underhill and
Ozinsky 2002). An important function of the innate immune response is to
discriminate between pathogens and self. Phagocytosis mediated by the Fc
receptor is strongly pro-inflammatory (Aderem 2003). Macrophages are more
efficient at ingesting bacteria if the microbes are opsonize by complement
receptor 3 (CR3), aM(32 integrin, or CD11 b/CD18 (Mad) (Ross 2000; van der
Laan et al. 1999). Most macrophages also express SR-A, which is able to bind
whole bacteria, as well as IPS (Chow et al. 1999; Hughes, Fraser, and Gordon
1995),
Many signaling pathways are involved in particle internalization.
Internalization requires the rearrangement of the actin cytoskeleton, extension of
11

plasma membrane and engulfment (Underhill and Ozinsky 2002). Some of the
signaling molecules involved in this process include phosphoinositide 3-kinases
(PI 3-kinase), phospholipase C (PLC), Rho kinase (a serine/threonine-specific
enzyme), enzymes that hydrolyze guanosine triphosphate (GTPase) and protein
kinase C (PKC). PI 2-kinase is involved in immunoglobulin G (IgG) and
complement opsonized particles and bacteria and both PI2-kinase and PLC play
a role in the formation of actin filaments beneath the site of particle contact,
which then activates PKC. PKCs are also required for cytokine production and
activation of respiratory burst.

Oxidative Burst
The process of respiratory burst involves the release of ROS, which have
antimicrobial activity. Upon internalization, the phagosome is then fused with a
lysosome containing degradative enzymes and other microbicidal agents.
Therein, internalized pathogens (or any other ingested materials) are digested
and eliminated; some parts of the digested materials may be retained within the
phagocytic cell for its own use. Phagocytes express a multicomponent of
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase whose
components are separated between the cytosol and plasma membrane. The
cytosolic component is composed of p47ph07 p67ph07 p40phox and GTPase
Rac1/Rac2. The plasma membrane is composed of the flavocytochrome
subunits gp91ph07 and p22phox (Forman and Torres 2001). In the case of a
bacterial infection, Fc receptors on an opsonized microbe activate NADPH
oxidase on phagosomal membranes (Maderna and Godson 2003; Underhill and
12

Ozinsky 2002), by translocation of cytosolic components to the plasma
membrane, which leads to the eventual reduction of oxygen to superoxide anion
(Fig. 3). This leads to the generation of other oxidizing agents including hydroxyl
radicals and hydrogen peroxide superoxide dismutase (SOD) (Bogdan and
Rollinghoff 2000). Activated macrophages are also able to activate nitric oxide
synthase to produce nitric oxide (NO), which is also a potent antimicrobial
(Bogdan, Rollinghoff, and Diefenbach 1997). Antigens from digested pathogens
are presented to other immune cells and the rest of the products are either
eliminated by exocytosis or retained by phagocyte for its own use. Presentation
of these antigens to other immune cells is an important aspect of communication
within the immune system.
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Antigen Presentation
An important function of the innate immune response is to communicate
the presence of infection with the rest of the immune system. One way this is
achieved is through the display of protein antigen fragments from the digested
pathogen on the surface of antigen presenting cells (APCs) such as B
lymphocytes, dentritic cells and macrophages, in association with MHC II. These
antigens are then recognized by CD4+Th cells, which elicit and also regulate the
specific immune response.
MHC II molecules are highly polymorphic and consist of a and (3
heterodimers, which is assembled in the endoplasmic reticulum with the
chaperone called invariant chain (li). Once the molecule is transported to the
frans-Golgi network, the MHC ll-li complex is targeted to the li cytoplasmic tail
(Pieters 1997). This complex is then transported to specialized compartments
known as MIICs and ClIVs. The complex then goes through very limited
proteolysis of li, with aspartic and cysteine proteases, which results in a complex
of a p with li-derived peptides known as class II invariant chain peptide (CLIP)
(Bryant and Ploegh 2004). At the endosomal site, CLIP is exchanged for
antigenic peptides (Pieters 1997). This process is catalyzed by human leukocyte
antigen (HLA)-DM molecules in humans and l-E molecules in mice (Schmid et al.
2006; Weenink and Gautam 1997). This complex is then transported to the
plasma membrane where the antigen peptide is exposed and detected by CD4
Th cells.
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CD4+ protein is an integral membrane glycoprotein on the surface of Th
lymphocytes, which acts as an accessory molecule for activation of this T cell
subset (Fig. 4). Studies have demonstrated direct interaction on HLA-DR
molecules on ARCs and CD4+cells (Nag et al. 1993). Upon binding of the CD4 to
MHC II, it undergoes conformational change and oligomerizes to form a multidimeric structure which is more stable (Sakihama, Smolyar, and Reinherz 1995).
Other adhesion molecules contribute to the strength of the bond including CD2
CD28 and CD45R (Goldsby et al. Immunolgy 2003). An essential component of
CD4 and MHC II interaction is the T cell antigen receptor/CD3 complex
(TCR/CD3), which is required for Th cell activation. Interaction of the TCR/CD3
complex leads to activation of PKC and ras pathways. CD28 activation leads to
phosphorylation of the tyrosine on the CD28, resulting in the stabilization of the
mRNA required for interleukin-2 (IL-2) translation (Schneider et al. 1999).
Combined CDS and CD28 activation results in high production of interferon
gamma (IFN-y) and other Th cytokines required for further macrophage activation
and specific immune responses.
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Cytokines
Cytokines are multi-functional pleiotropic proteins primarily released by
immune cells that play important roles in the defense response to external
organisms, preventing or minimizing the risk for serious infection (Holloway, Rao
and Shannon 2002). These soluble mediators act as messengers both within the
immune system and between the immune system and other systems of the body.
Activation of macrophages results in the release of inflammatory cytokines such
as tumor necrosis factor alpha (TNF-oc), interleukin-1 alpha (IL-1a), interleukin-1
beta (IL-1p) and interleukin-6 (IL-6). These cytokines attract other leukocyte
populations to the site of infection. Cytokines released by macrophage and other
leukocytes regulate the innate immune response. This study will focus on TNF-a
IL-1a, IL-1 p, IL-6, IL-10 and interleukin-12 (IL-12).
The main cellular sources of IL-1 are monocytes, macrophages and B
cells. IL-1 stimulates Th cells and can trigger fever by enhancing prostaglandin
E2 (PGE2) synthesis by the vascular endothelium of the hypothalamus (Warren
1990).
TNF-oc is released by macrophages, mast cells and NK cells and induces
the release of IL-1 in macrophages. Like IL-1, TNF-oc is also able to induce fever.
IL-6 is produced by monocytes, macrophages and Th2 cells. In addition to
stimulation of acute phase proteins in the liver, it acts as a growth factor for
mature B cells and induces their maturation into antibody-producing plasma cells.
It also plays a role in T cell activation and induces IL-2 required for cytotoxic T
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cell function. IL-6 is also involved in the inhibition of TNF-a production, providing
a negative feedback for limiting the inflammatory response.
IL-10 is released by a variety of cell types, including T cells and activated
B cells. It reduces antigen specific T cells proliferation and inhibits of IFN-y
production by NK cells and macrophages, thus inhibiting Th1 and inducing Th2
response by activating B cells.
IL-12 is also an inflammatory cytokine released by macrophages and
activated B cells. It enhances cytotoxic T cells, induction of activated T cell and
NK cell proliferation and IFN- y production by NK cells and T cells, which is
critical for further macrophage activation. Its production is inhibited by interleukin4 (IL-4) and IL-10.

Brief Overview of Immune-CNS Communication
Studies have shown that the immune and central nervous systems do not
function independently and are intimately linked via bidirectional communication.
The CNS is able to communicate with the immune system via endocrine
hormones and direct innervation of lymphoid tissues. Conversely, the immune
system communicates with the CNS mainly via cytokines (Fig. 5)
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Regulation of CNS by Immune System
Cytokines play a crucial role in cell-to-cell communication and cellular
activation. Cytokines are involved in both immunological and pathological
processes making them immunoregulators and neuromodulators. Several
cytokines such as IL-1, IL-6 and TNF-a are produced in the brain and are able to
stimulate the hypothalamic pituitary-adrenal axis (HPA) axis. However, unlike
peripheral cytokines released by peripheral immune cells, the cytokines released
in the brain by microglia or infiltrating immune cells, can also act like growth
factors, inhibiting or enhancing neural cell death. For example, microglia,
astrocytes and endothelial cells (Allan 2000; Rothwell and Luheshi 2000), as well
as infiltrating neutrophils and macrophages (Kielian and Hickey 2000), have all
been shown to increase their level of cytokine expression after cerebral insult. IL1 has been associated with the edema noted after hypoxic and ischemic insult
(Botchkina et al. 1997; Meistrell et al. 1997). Once glial cells are activated, tightly
regulated feedback mechanisms can lead to further activation of CNS-specific
populations.
Cytokines can also function as motivational signals, changing the
organism’s priorities when exposed to pathogens, resulting in changes in
neuroendocrine responses and behavioral patterns, commonly referred to as
“sickness behavior.” These behavioral responses include activity, anorexia,
somnolence, hyperalgesia and allodynia (Dantzer 2005; Hopkins 2007). Studies
have shown that a dysregulation of the cytokine balance may lead to symptoms
of depression due to lower level of anti-inflammatory cytokines and higher levels
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of pro-inflammatory cytokines (Szelenyi and Vizi 2007). Cytokines are able to
exert their effect directly and indirectly via secondary messengers (Szelenyi,
Kiss, and Vizi 2000). There are several ways by which cytokines can exert their
effects in the CNS: First, cytokines originating in the periphery are able to enter
the brain parenchyma after crossing the blood-brain barrier (BBB) or through
areas that lack a BBB (Licinio, 1997). This was shown by the presence of human
recombinant IL-1a in mouse cortex after its subcutaneous injection, without the
elevation of mouse IL-1a (Banks et al. 1991). Second, most cytokines, such as
the IL-1 family, TNF-oc, transforming growth factor beta (TGF-(3 and interferon
alpha (IFN-a) and their receptors have been shown to exist within the neurons in
the CNS, and are constitutively expressed in neurons (Iosif et al. 2006;
Tabarean, Korn, and Bartfai 2006). Third, peripheral cytokines can influence the
CNS through the brain vasculature via secondary messengers. IL-1 is also able
to interact with IL-1 receptors on endothelial cells of the vasculature, stimulating
signaling molecules such as NO or prostaglandins, which can locally influence
neurons (Correa et al. 2007). Cytokines are also able to exert their effects on the
CNS via the vagus nerve.
The vagus nerve innervates points of pathogen entry (such as the lung) and
peripheral immune organs that screen for pathogens (such as the liver). Studies
have also shown that intraperitoneal (i.p.) injection of immune stimuli, such as
LPS and pro-inflammatory cytokines, lead to an increase in the firing rate of the
sympathetic nerve innervating the spleen (Besedovsky and del Rey 1996). It has
also been shown that low levels of peripheral administration of IL-1p or LPS,
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induces neural activation within the area postrema and the nucleus tractus
solitarius (NTS) in the CNS (Brady et al. 1994; Ericsson, Kovacs, and
Sawchenko 1994) as evidenced by increases in neural cFos expression.
Sickness behavior and cfos activation, and hypothalamic norepinephrine (NE)
secretion have been shown to be inhibited by subdiaphragmatic vagotomy
following i.p. injection of LPS (Dantzer et al. 1998; Fleshner et al. 1995;
Gaykema, Dijkstra, and Tilders 1995; Watkins et al. 1995).

Regulation of the Immune System by the CNS
Studies have shown that there are several routes by which the immune,
endocrine and the CNS communicate. These networks allow the CNS to regulate
the immune system locally at the site of inflammation, regionally in the immune
organs and systemically through hormones (Eskandari and Sternberg 2002). The
CNS is able to mediate its influence on the immune system through
neuroendocrine output and autonomic nervous connections. Studies have
demonstrated noradrenergic (NA) sympathetic innervation in spleen of humans
(Kudoh, Hoshi, and Murakami 1979), mice (Reilly et al. 1979), and rats (Bellinger
et al. 1989) amongst other species.

Spleen Innervation
Approximately 98% of nerve fibers in splenic nerve of young adult rats are
sympathetic and derived from the superior mesenteric-coeliac ganglion (Bellinger
et al. 1989). NA nerves enter the spleen as a dense perivascular plexus
associated with the splenic artery and continue along the capsule and trabeculae
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(Mignini, Streccioni, and Amenta 2003). The NA nerves then follow the central
arterial and branch into the white pulp of the spleen. Some of these fibers travel
into the PALS, which have a high population of T lymphocytes (Ader, Felten, and
Cohen 2001). Immunocytochemical localizing studies carried out with tyrosine
hydroxylase (TH), the rate-limiting enzyme for the synthesis of NE, combined
with electron microscopy, have shown diffuse contacts between nerves,
lymphocytes and macrophages (Felten and Olschowka 1987). At the marginal
sinus and zone, TPT nerve fibers have been shown to run adjacent to
macrophages, B lymphocytes, in addition to parafollicular zone, TFT are adjacent
to T lymphocytes and peripheral follicular B lymphocytes (Stevens-Felten and
Bellinger 1997; Williams and Felten 1981).
Neuropeptide Y (NPY)+ nerves have also been found along the
vasculature and in lymphoid compartments of the spleen (Bellinger et al. 1990).
Studies have reported that NPY+ nerve distribution closely overlaps the NA
nerves. NPY+nerves are associated with specific lymphoid parenchymal
compartments of the spleen and are also in close contact with macrophages and
lymphocytes. They are also present in the marginal zone (Felten et al. 1988).
Substance P and calcitonin gene-related peptide nerves also have a
similar distribution pattern with NA nerves (Mignini, Streccioni, and Amenta
2003). Other neuropeptidergic nerves exist within the spleen; however, they are
either not considered to be sympathetic.
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Communication Pathways
There are two major pathways by which the CNS regulates the immune
system. The first is the HPA axis, which primarily involves hormones. The second
is the autonomic nervous system, through release of catecholamines and
acetylcholine from sympathetic and parasympathetic nerves, respectively.

The HPA Axis
Once the host is exposed to pro-inflammatory stimuli, such as physical
trauma or exposure to bacterial LPS, there is a marked increase in cytokine
synthesis and release by immunocytes, particularly TNF-a and IL-1. IL-1p has
the ability to lead to a wide range of effects, including activation of the HPA axis.
IL-1 pis a potent inducer of the expression of the immediate early gene, cfos,
which is transcribed within the brain in different regions, in response to various
stimuli, including epilepsy and seizures (Conde et al. 1999; Fu et al. 1993). IL-1
acts centrally in the brain to stimulate the paraventricular nucleus (PVN) of the
hypothalamus. Studies have shown that IL-1 up-regulates cFos messenger
ribonucleic acid (mRNA) in the PVN, in addition to causing an increase in
corticotropin releasing hormone (CRH) (Brady et al. 1994). CRH is released from
the PVN into the hypophyseal portal blood supply around the pituitary gland
(Grinevich et al. 2001). CRH then stimulates the expression and release of
adrenocorticotropic hormone (ACTH) from the anterior pituitary gland. Ultimately,
this leads to the expression and release of glucocorticoids from the adrenal
glands.
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Glucocorticoids, such as corticosterone (in mice) or cortisol (in humans)
regulate a variety of immune-related genes and functions. Glucocorticoids can
alter cytokine expression, leading to a shift from a Th1 (cell-mediated) to a Th2
(humoral) response.
Hyperactivity in the HPA axis has been implicated in several inflammatory
diseases and can lead to an increased susceptibility to viral infections, prolonged
wound healing or decreased antibody production following vaccination
(Eskandari and Sternberg 2002; Heijnen 2007).
Glucocorticoids activate these immunoregulatory pathways through the
glucocorticoid receptor and are able to affect cytokine signaling at multiple levels
including direct transcription facto inhibition, which exerts immunosuppressive
effects and is capable of interfering with other signaling pathways, such as the
NF-kB, and Activator protein 1 (AP1) to repress gene transcription in order to
mediate anti-inflammatory actions (Eskandari, Webster, and Sternberg 2003;
Heijnen 2007; Sternberg 2006). Glucocorticoids can also increase the synthesis
of IL-1 receptor antagonist, thereby counteracting the pro-inflammatory effects of
IL-1.

The Sympathetic Nervous System (SNS) Pathway
The SNS regulates the immune system at regional, local and systemic
levels. The lymphoid organs, lymph nodes, spleen, thymus and mucosaassociated lymphoid tissue all have extensive sympathetic innervation (Bellinger
et al. 2005). These nerve fibers originate in the CNS and terminate in either
synaptic-like direct contacts, or in the immediate vicinity of, lymphocytes,
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monocytes and macrophages. As with HPA activity, stimuli such as strenuous
exercise and LPS can modulate the immune response by activating the SNS.
However, rather than a systemic release of glucocorticoids, activation of the SNS
results in the release of the catecholamines, epinephrine (EPI) from the adrenal
gland and NE from sympathetic nerves. Upon stimulation, NA fibers in the
primary and secondary lymphoid organs release NE which diffuses through the
parenchyma and interacts with immunocytes (Madden et al. 1997; Schorr and
Arnason 1999).
NE modifies immune activity by binding to adrenergic receptors expressed
on the surface of various immunocytes (Bishopric, Cohen, and Lefkowitz 1980;
Landmann et al. 1984; Williams, Snyderman, and Lefkowitz 1976). The
predominant adrenergic receptor expressed on lymphocytes and macrophages is
the beta 2 adrenergic receptor (P2AR), a G protein-linked receptor integrated into
the plasma membrane (Fig. 6) (MacGregor et al. 1996). Previous studies have
demonstrated that the activation of the p2AR in macrophages suppresses LPS
mediated IL-ip and TNF-a production through the inhibition of transcription factor
NF-kB, the major pro-inflammatory regulator of signaling in macrophages. In
addition, these G-protein coupled cell surface structures are able to alter free
radical release and migration. Activation of p2AR by EPI and NE results in the Gdependent activation of adenylate cyclase and an eventual increase in
intracellular cyclic adenosine monophosphate (cAMP) (Bach 1975; Staehelin et
al. 1985). This leads to stimulation of protein kinase A (PKA), phosphorylation of
the transcription cAMP response element binding protein (CREB), and binding of
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CREB to the cAMP-responsive element sites in the promoter of a number of
cAMP responsive genes. In immune cells, the increase in intracellular cAMP
leads to the inhibition of pro-inflammatory responses, through the decrease in
phosphorylation/degradation of inhibitor kappa B (IkB), followed by an increase in
IkB synthesis and stability (Chong et al. 2002; Tan et al. 2007). In non-immune
cells, p2AR stimulation activates other intracellular signaling mediators such as
PLC, PI-3-kinase, PKC, Bruton’s tyrosine kinase and mitogen-activated protein
kinase (MARK) pathways, leading to activation of a number of these intracellular
signaling intermediates are also involved in signaling cascades activated by
immune related receptors such as CD40 and B-cell receptor, which may
contribute to the effects of NE on the lymphocyte function (Kohm et al. 2000).
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Brief Overview of Spaceflight and Immunity
In vivo flight studies performed in rat models have shown changes in mass
(Chapes et al. 1999; Grindeland et al. 1990; Mandel and Balish 1977) as well as
hypoplasia (Durnova, Kaplansky, and Portugalov 1976) in both the spleen and
thymus. Rats flown on both the COSMOS and space shuttle platforms have
shown decreases in peripheral leukocyte and lymphocyte counts (Allebban et al.
1994). Functionally, exposure to the spaceflight environment has resulted in
decreases in the proliferative responses of lymphocytes isolated from lymph
nodes (Nash and Mastro 1992) and spleen (Grove, Pishak, and Mastro 1995).
Other studies have shown changes in cell-mediated immunity (Taylor and
Janney 1992), cytokine production (Crucian, Cubbage, and Sams 2000; Gould et
al. 1987; Lesnyak et al. 1993; Sonnenfeld 1994), signal transduction (Cogoli
1997), and NK cell activity (Kaur et al. 2004). Furthermore, these findings are not
limited to animal models. Blood collected from astronauts selected from 11 of the
first 12 US space shuttle missions indicate that the spaceflight environment leads
to decrements in both the numbers of circulating leukocytes, as well as, the
proliferative response to mitogenic challenge with phytohemagglutinin (PHA)
(Taylor, Neale, and Dardano 1986).

Radiation and Immunity
A great deal of research has been done on the biological effects of y-ray
and x-ray radiation. However, there is comparatively little data on the effects of
low-dose ionizing radiation on the immune and central nervous systems. During
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a Mars mission, models predict that every nucleus of every cell in an astronaut’s
body would likely be hit by at least one proton or secondary electron. Studies
have reported a reduction in mouse thymus and spleen masses after exposure to
2-3 Gy of iron radiation (Pecaut et al. 2002). The effects of whole-body irradiation
with y-ray, proton, iron and silicon have been investigated (Gridley et al. 1995;
Gridley et al. 2001; Gridley, Pecaut, and Nelson 2002; Pecaut et al. 2002;
Pecaut, Nelson, and Gridley 2001) and it has been shown they alter cellmediated cytotoxicity (Shankar et al. 1999), hematopoiesis (Harrington et al.
1997), hematological parameters (Gridley et al. 2001; Pecaut, Nelson, and
Gridley 2001) and leukocyte distribution patterns (Gridley et al. 1995; Gridley et
al. 2002; Gridley, Pecaut, and Nelson 2002; Pecaut, Nelson, and Gridley 2001).
Circulating and splenic white blood cell (WBC) counts have also been reported to
reduce to approximately 20% of control mice four days after whole-body
exposure to 3 Gy of iron radiation (Pecaut et al. 2002).

Radiation and Macrophage Function
Many studies on effects of radiation (y and x-ray) on macrophages have
demonstrated significant changes in macrophage function. As mentioned above,
cell signaling is crucial for eliciting a proper macrophage response to a foreign
pathogen. However, production of free reactive oxygen intermediates is also
associated with ionizing radiation. This can lead to changes in gene expression
and signal transduction via oxidation of phospholipids and deoxyribonucleic acid
(DNA). Hydrolysis of oxidized lipids leads to an increase in secondary
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messengers, such as arachidonic acid, diacylglycerol and ceramide, which leads
to the activation of kinases. As a result of oxidation of free S-H groups on
membrane-associated protein phosphatases, kinases are further activated. This
activation leads to phosphorylation of transcription factors, which control gene
expressions (Stulik et al. 1999).
Macrophages primed with radiation have also been shown to represent a
true intermediate activation state and result in a stable LPS-response phenotype
(Lambert and Paulnock 1987). Both in vivo and in vitro studies on murine
macrophages have shown enhanced macrophage function. For example, Cheers
et al. (Cheers and Waller 1975), demonstrated increased clearance of Listeria
organism post whole-body irradiation. Low-dose radiation in vivo has also shown
to enhance concanavalin A (ConA) induced proliferation of splenocytes by
macrophages (Ibuki and Goto 2000). Increased C3b-mediated and decreased
Fc mediated phagocytosis have also been demonstrated (Lambert and Paulnock
1987).
Similarly, 02' production by macrophages increases after low-dose in vivo
radiation. This 02‘ production leads to the generation of peroxynitrides by
reacting with NO. Studies have also shown a dose-dependent radiation-induced
increase in NO release by macrophages when subsequently exposed to LPS
(McKinney et al. 1998).
Radiation-induced increases in TNF-oc and IL-6 released by macrophages
have also been reported (McKinney, Hosoi). Radiation is able to increase levels
of 13-hydroxyoctadienoate, which is implicated in LPS-induced expression of
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TNF-a by macrophages. Transcriptional activation of IL-6 is due to enhanced
binding of NK-kB, which has been shown to be induced and activated as a result
of ionizing radiation (Hosoi et al. 2001).

Significance and Hypothesis
Given that there are clear links between the immune and central nervous
systems, any disruption in communication could be particularly important when
dealing with long-term interplanetary missions. In healthy individuals, the
homeostasis maintained by the communication between the CNS and immune
system is crucial for eliminating pathogens. During spaceflight, astronauts will be
exposed to environmental factors such as isolation, psychological stress,
microgravity and radiation, which can potentially lead to disturbance of the
homeostasis maintained by the CNS and immune system. Several LEO
spaceflight (i.e. mostly within the protection provided by the Van Allen Belts)
studies have shown that the microgravity aspect of the spaceflight environment
changes virtually all immune parameters. In addition, low-dose radiation is known
to significantly influence the immune system.
The overall hypothesis of this study is: Exposure to spaceflight
environment (microgravity and radiation) influence immune responses by
upregulating innate immune response, altering cytokine expression and
ultimately influencing CNS-immune communication.
This study characterizes the inertial and radiation aspects of the
spaceflight environment and their respective impact on the inflammatory

33

response. In particular, effect of spaceflight on ex vivo inflammatory response will
be determined. The time course of proton radiation effects on phagocytic function
and CNS-immune communication in response to an in vivo challenge to E. coli
will also be characterized. Finally, using body-only proton radiation, we will begin
to characterize the role played by SNS and HPA signaling on radiation-induced
changes in phagocytic function.

34

CHAPTER TWO
EFFECTS OF SPACEFLIGHT ON INNATE IMMUNE FUNCTION AND
ANTIOXIDANT GENE EXPRESSION

Farnaz P. Baqai1’2, Daila S. Gridley1,2, James M. Slater1, Xian Luo-Owen1, Louis
S. Stodieck , Virginia Ferguson3, Stephen K. Chapes4, Michael J. Pecaut1,2.

1

Department of Radiation Medicine LLURM Molecular Radiation Biology
Laboratories, 2Loma Linda University Department of Basic Sciences (Division of
Microbiology& Biochemistry), 3BioServe Space Technologies, University of
Colorado at Boulder, 4Kansas State University in Manhattan, KS.

Correspondence: Farnaz P. Baqai, Chan Shun Pavilion, Room A-1010, 11175
Campus Street, Loma Linda University, Loma Linda, CA 92354.
Tel: (909) 558-7215, Fax: (909) 558-0825, email: fpirayesh05b@llu.edu

J Appl Physiol. 2009 Apr 2.

35

Abstract
Spaceflight conditions have a significant impact on a number of
physiological functions due to psychological stress, radiation and reduced
gravity. To explore the effect of the flight environment on immunity, C57 black 6
(C57BL)/6NTac mice were flown on a 13-day space shuttle mission (STS-118).
In response to flight (FIT), animals had a reduction in liver, spleen and thymus
masses compared to ground (GRD) controls (p<0.005). Splenic lymphocytes
monocyte/macrophages and granulocyte counts were significantly reduced in the
flight mice (p<0.05). Although spontaneous blastogenesis of splenocytes in FLT
mice was increased, response to lipopolysaccharide (LPS), a B cell mitogen
derived from E. coli, was decreased compared to GRD mice (p<0.05). Secretion
of IL-6 and IL-10, but not that of TNF-a by LPS-stimulated splenocytes was
increased in FLT mice (p<0.05). Finally, many of the genes responsible for
scavenging ROS were up-regulated after flight. These data indicate that
exposure to the spaceflight environment can increase anti-inflammatory
mechanisms and change the ex vivo response to LPS, a bacterial product
associated with septic shock and a prominent Th1 response.

Materials and Methods
Animals and Housing
Female C57BL/6 mice were ordered from Taconic Laboratories (Hudson
NY) and were delivered to the National Aeronautics and Space Administration
(NASA) Space Life Sciences Laboratory (SLSL) at Kennedy Space Center at 7
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weeks of age and adapted to the facility and experiment cage conditions. Female
mice were used as they are less aggressive and have been used in previous
space-flight studies (Pecaut et al. 2003). However, it is important to note that the
estrous cycle was not characterized in this study. At 9 weeks old, mice were
assigned to experimental groups by matching total body mass and lean-body
mass. Twenty-four FLT and 24 GRD control mice were housed in animal
enclosure module (AEM) hardware equipped with solid food bars and a water
dispenser. An additional 12 control mice were housed in standard vivarium (VIV)
conditions. Using telemetry from the shuttle, the AEM-housed GRD controls were
exposed to environmental conditions comparable to flight animals (i.e.
temperature, humidity, C02) on a 48-hour delay. The mice were treated once
with placebo or therapeutic agent approximately 24 hours prior to launch (N=12
mice per group). Only placebo treated mice were used for immunological
assessments. The FLT groups were flown in Space Shuttle Endeavour (STS118) for 13 days. Within 3-6 hours after landing of the space shuttle, FLT and
GRD mice were evaluated for muscle strength and scanned with nuclear
magnetic resonance (NMR) imaging to assess lean and fat mass composition.
Mice were then euthanized with 100% C02 (Pecaut et al. 2000). This animal
study was approved by Loma Linda University, NASA, University of Colorado
and Amgen Institutional Animal Care and Use Committees (lACUCs).

Specimen Collection
At euthanasia, spleen, liver and thymus were harvested and weighed. A
quarter of the spleen was used to obtain leukocyte numbers at the SLSL. The
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rest of the spleen was shipped on wet ice via overnight courier to Loma Linda
University in screw cap tubes containing RPMI 1640 (Cellgro, Mediatech Inc.
Herndon, VA) supplemented with 20% fetal bovine serum (FBS) (ATCC
Manassas, VA). The other organs were placed in sterile cryovials, snap frozen in
liquid nitrogen, placed on dry ice and shipped to Loma Linda University.

Leukocyte Numbers in Spleen
At the SLSL, single celled suspension of splenocytes was obtained by
grinding !4 of the spleen in a 5 mL test tube with sterile wood sticks in 2 mL of
RPMI 1640 supplemented with 10% FBS, and passing it through a 40 pm nylon
mesh. The tube was washed with an additional 1 mL of RPMI 1640. Splenocytes
were then washed, centrifuged at 300 g, and resuspended in 1 mL of RPMI
1640. Cells were then counted with the ABC Vet Hematology Analyzer (Heska
Corp., Waukesha, Wl). Overall WBC, lymphocyte, monocyte/macrophage and
granulocyte counts and percentages were obtained from the analyzer. Total
counts were calculated based on mass using the following formula: Total count =
(Automated count / Mass of 14 spleen) x mass of whole spleen.

Spontaneous and Mitogen-Induced Blastogenesis
Upon arrival at Loma Linda University, single cell suspensions of
splenocytes were obtained following the method described above. After the first
wash, erythrocytes were lysed in 2 mL of lysing buffer containing 5 mM
potassium bicarbonate, 77 mM ammonium chloride and 49 mM
ethylenediaminetetraacetic acid (EDTA), at 4°C for 10 minutes. The lysing
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reaction was terminated by adding 2 mL of RPMI 1640. Cells were then
centrifuged, washed twice and resuspended in 1mL of RPMI 1640.
For spontaneous blastogenesis, 50 pL of cells were dispensed into flat-bottom
96-well microculture plates in triplicates. One hundred-fifty pL RPMI 1640
supplemented with 10% FBS and 50 pi of [3H] thymidine [3H] TdR (specific
activity = 50 Ci/mmol; ICN Radiochemicals, Irvine, CA) were added to the cells
and the plates were incubated for 4 hours at 37°C. Readings were later
normalized to 2 X 106 cells/mL based on the original cell counts.
For mitogen-induced blastogenesis in the spleen, cells were adjusted to 2
X 106cells/ml_ and 100 pi aliquots were plated in triplicates into wells of 96-well
flat bottom microculture plates. One hundred pi of 3.3 X 10'3mg LPS (Sigma
Chemical, St. Louis, MO) were added in triplicate; control wells with no mitogens
were included. Fifty mL of [3H]TdR (specific activity = 50 Ci/mmol) was added to
each well during the last 4 hours of a 48-hour incubation at 37°C.
For both assays, cells were collected with a multiple sample harvester
(Harvester 96 Mack lll-m; Tomtec, Hamden CT), and the incorporated
radioactivity was quantified on a 1450 Microbeta Trilux Liquid Scintillation and
Luminescence Counter (EG&G-Wallac, Turku, Finland). Stimulation index (SI) for
the mitogen was calculated as follows: SI = [counts per minute (cpm) with
mitogen - cpm without mitogen] / (cpm without mitogen).
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LPS-Induced Cytokine Secretion
Spleen leukocytes were diluted with RPMI 1640 supplemented with 10%
FBS and adjusted to 2 X 106 cells/mL One hundred pL aliquots were plated into
96-well, flat-bottom microculture plates and 100 pL of 3.3 X 10'3 mg IPS was
immediately added to each well. Cells were incubated at 370C for 48 hours.
Supernatants were aspirated and centrifuged to remove debris. Levels of IL-1p,
IL-6, IL-10, IL-12 and TNF-a were quantified using enzyme-linked
immunosorbent assays (ELISA) according to the manufacturer’s instructions
(R&D Systems, Minneapolis, MN) using the appropriate dilutions.

RNA Purification
Frozen liver tissue was pulverized into a powder in a mortar and pestle
submerged in liquid nitrogen. RNA was extracted using Trizol (Invitrogen
Carlsbad, CA). Following incubation of homogenized samples at room
temperature for 5 minutes, 0.2 mL of chloroform was added and samples were
incubated for 3 minutes. This mixture was then centrifuged at 12,000 g for 15
minutes at 4°C. Isopropyl alcohol (0.5 mL) was added to the aqueous phase in a
sterile RNase-free tube and samples were incubated at room temperature for 10
minutes, prior to centrifugation at 12,000 g for 15 minutes at 4°C. The pellet was
washed with 1 mL of 70% ethanol and re-centrifuged at 7,500 g for 5 minutes at
4°C. Ethanol was removed with a pipette and the pellet was allowed to air dry for
5 minutes. Pellet was dissolved in 50 pL of nuclease-free water. The RNA was
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further purified using an RNeasy RNA purification kit (Qiagen, Valencia, CA)
following the manufacturer’s instructions.

RNA Microarrays
RNA quality was assessed using the Agilent 2100 Bioanalyzer (Santa
Clara, CA). The integrity of the RNA was determined by looking at 18 and 28s
rRNA peaks and by RIN (RNA integrity number). RNA concentrations were
measured using the nano drop and all samples had 260/280 ratios above 2.0 and
260/230 ratios above 1.7. An equal amount of RNA (1 mg) was taken for all
samples and reverse transcription was done using RT2 First Strand Kit
(SuperArray Biosciences, Frederick, MD). Polymerase chain reactions (PCR)
were performed to evaluate expression of 84 genes using RT2 profiler™ PCR
array PAMM-065 (Mouse Oxidative Stress and Antioxidant Defense, SuperArray
Frederick, MD) on the ABI Fast 7900 using RT2 Real-Time™ SYBR Green PCR
Master Mix PA-011. Thermocycler parameters were 95°C for 10 minutes,
followed by 40 cycles of 95°C for 15 seconds and 60°C for 1 minute. Relative
changes in gene expression were calculated using the DDCt (threshold cycle)
method. This method first subtracts the ct (threshold cycle number) of the geneaverage ct of the 3 house keeping genes on the array (hypoxanthine
phosphoribosyltransferase 1(HPRT1), Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), and actin beta (ACTB)) to normalize to the RNA
amount. Finally the DDCt was calculated: normalized average ct of the FLT group
- normalized average ct of GRD group. This DDCtwas raised to the power of 2 in
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order to calculate the fold change. The genes of interest included those involved
in oxidative stress. Six mice per group were used for this analysis.

Statistical Analysis
The data were evaluated by using Student’s t test (Systat, Systat
Software, Richmond, CA). Organ masses were normalized to both body mass
and brain mass. Studies have shown that spaceflight has significant effects on
body weight (Gridley et al., 2003), reflecting changes in muscle weight and body
water content. However, the brain is considered to be the most stable organ and
has been used to normalize organ masses (Chapes et al., 1999). As the FIT and
GRD mice were evaluated on separate days, the VIV control mice were used to
normalize the data, thus minimizing any day-to-day variability. Half of the VIV
mice were euthanized on each day of assessment. For example, the flight data
were normalized using the following equation: NOM = [(Individual data point from
FLT Day)/(Average of VIV Controls from FLT Day)] x (Average of all VIV controls
on both FLT and GRD days). A similar, corresponding equation was used to
normalize the data from the GRD controls. P values of <0.05 and <0.1 were
selected to indicate significance and trend, respectively.

Results
Organ Masses
There was no significant change in the brain masses between the FLT
and GRD groups. As indicated in Table 1, there were significant decreases in
masses of spleen (p<0.005), liver (p<0.001), and thymus (p<0.001). When
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Table 1. Organ masses normalized to body mass and brain mass. Values are
means ± SEM for 12 mice/group *p<0.05, **p<0.001 GRD vs. FLT.
FLT

GRD
Organ mass (mg)
Brain
Spleen

431 ±4.0

435 ± 3.8

55 ± 1.2

47 ±1.9*

Liver

736 ± 22.2

634 ±13.9**

Thymus

108 ±2.0

63 ± 1.7**

Normalized to body mass (mg/g)
Spleen
Liver

3.0 ±0.2

3.0 ±0.5

39.4 ±3.4

37.4 ±3.2

5.8 ±0.4

4.3 ±1.1**

Spleen

0.1 ±0.0

0.1 ±0.0

Liver

1.7 ± 1.4

1.5±0.1**

Thymus

0.3 ±0.0

0.2 ±0.0**

Thymus
Normalized to brain mass (mg/g)
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normalizing to body mass, there was a significant decrease in only the thymus
(p<0.001) in FLT group compared to GRD group. However, significant decreases
were observed for liver (p<0.001) and thymus (p<0.001) when normalized to
brain mass, with a similar trend observed for spleen (p=0.065).

Leukocyte Subpopulations in Spleen
As shown in Fig. 7, there was a significant effect of spaceflight conditions
on the WBC counts (p<0.05). In addition, there were significant space-induced
decreases in all leukocyte subpopulations: lymphocytes (p<0.001),
monocyte/macrophages (p<0.005) and granulocytes (p<0.05). There were no
significant changes in lymphocyte, monocyte/macrophage and granulocyte
percentages (Table 2), however a trend (p=0.065) was observed with
monocyte/macrophages of FLT animals.
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Figure 7. Effects of spaceflight on white blood cell and major leukocyte
population counts in spleen. Data were obtained with an automated
hematology analyzer. Each bar represents mean ± SEM (n=12/group), a
p<0.05, b p<0.005, c p<0.001 GRD vs. FLT.
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Table 2. Percentage of leukocytes in spleen. Values are means ± SEM for 12
mice/group.
Subpopulation

GRD

FLT

% lymphocyte

64.80 ± 0.4

64.05 ± 0.5

% monocyte

10.93 ±0.2

10.32 ±0.2

% granulocyte

24.51 ±0.2

25.31 ±0.5
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Spontaneous and Mitogen-Induced Blastogenesis
Splenic spontaneous blastogenesis was elevated in the FLT mice
(p<0.001). There was a decrease in cpm of LPS-induced blastogenesis
(p<0.001) (Fig. 8). The stimulation index of LPS-induced blastogenesis was also
significantly reduced (p<0.005, data not shown).
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Figure 8. Effects of spaceflight on
spontaneous
and
mitogen-induced
blastogenesis in spleen. The data were
obtained by quantifying the amount of
[3H]TdR
incorporated.
Each
bar
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<0.001 GRD vs. FLT.
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Cytokine Secretion by Activated Splenocytes
Flight conditions had a significant effect on the levels of LPS-induced
TNF-a, IL-6 and IL-10 (Fig. 9), but not on IL-1(3 and IL-12 (data not shown). TNF. a in FLT mice was significantly lower than in GRD mice (p<0.001). On the other
hand, IL-6 and IL-10 levels were significantly higher in FLT mice compared to the
GRD mice (p< 0.05 and p<0.005, respectively).
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Figure 9. Effects of spaceflight on cytokine secretion by activated
splenocytes. Supernatants from splenocytes were obtained 48
hours after incubation with IPS. Cytokine concentrations were
evaluated using ELISAs. Each bar represents mean ± SEM
(n=12/group). a p<0.05, b p<0.001,c p<0.005, GRD vs. FLT.
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Gene Expression
The genes that were statistically significant (p<0.05) and varied between
FLT and GRD groups by more than 1.5 fold are presented in Table 3. Of the 84
evaluated genes, 8 were up-regulated and 4 were down-regulated. The greatest
enhancement occurred in myoglobin (Mb) (almost 143-fold), whereas the
greatest suppression was noted in Serpinblb (-3.6-fold).
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Table 3. Oxidative stress gene expression in liver. Values represent fold change
between GRD vs. FLT (p<0.05).
Fold Change

Up-regulated

Description

Aqr

Aquarius

1.71

Cygb

Cytoglobin

1.85

Fmo2

Flavin containing monooxygenase 2

1.72

Gpx6

Glutathione peroxidase 6

1.96

Mb

Myoglobin

142.98

Nox1

NADPH oxidase 1

2.58

Tmodl

Tropomodulin 1

2.94

Ucp3

Uncoupling protein 3

13.62

Down-regulated

Description

Fold Change

Idh1

Isocitrate dehydrogenase 1 (NADP+)

-1.69

soluble
Nox4

NADPH oxidase 4

-2.09

Scd1

Stearoyl-Coenzyme A desaturase 1

-3.00

Serpinblb

Serine peptidase inhibitor, clade B,

-3.64

member 1b
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Discussion
The spaceflight environment can have a dramatic impact on a variety of
immune parameters (Allebban et al. 1994; Crucian, Cubbage, and Sams 2000;
Kaur et al. 2004; Nash et al. 1992). However, differences in flight platforms,
mission durations, animal models, and housing conditions have sometimes made
interpretation of the results difficult. The data reported here are the result of a
rare opportunity in which we were able to repeat, and expand on, a previous
flight experiment using a mouse model (Gridley et al. 2003; Pecaut et al. 2003).
The organs of interest in these studies have been the spleen, thymus, and
liver. The spleen is the largest secondary lymphoid organ and the decrease in
mass reported here is similar to that of previous spaceflight experiments using
both rat and mouse models (Durnova, Kaplansky, and Portugalov 1976; Gridley
et al. 2003; Nash and Mastro 1992). In contrast, the thymus, site of T cell
maturation, has proven to be more variable, decreasing (Durnova, Kaplansky,
and Portugalov 1976; Jahns 1992), increasing (Pecaut, Simske, and Fleshner
2000) or remaining constant (Chapes et al. 1999; Congdon et al. 1996; Gould et
al. 1987), depending on the flight. Interestingly, there was a similar trend in
thymus mass after our previous flight, although the differences did not reach
significance (Gridley et al. 2003). Finally, the liver is responsible for numerous
biological activities that include production of complement components. We
found a significant decrease in liver mass. Although, to our knowledge, liver
mass has not been reported after other spaceflight studies, a decrease in Kupffer
cells and hepatic CYP450 cells in rats have been reported (Rabot S. 2000;
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Racine and Cormier 1992). Similar results were found when we normalized
organ masses to brain mass. In contrast, when normalized to body mass, there
were no significant differences in spleen and liver. We believe that normalizing to
brain mass more accurately reflect changes due to animal growth as the brain is
less susceptible to transient effects (e.g. dehydration) compared to total body
mass.
These changes in organ masses suggest that the mice have been subject
to psychological and/or physiological stress in flight or during landing.
Unfortunately, as we were unable to measure catecholamine or glucocorticoid
levels, we cannot conclude whether this was an acute or chronic response.
However, exposure to the spaceflight environment has already been shown to
induce the release of hormones and neurotransmitters such as catecholamines
and glucocorticoids (Meehan, Whitson, and Sams 1993; Stowe, Pierson, and
Barrett 2001; Tipton, Greenleaf, and Jackson 1996). Ground-based studies have
shown that chronic elevation of these factors is damaging, often leading to the
atrophy of lymphoid tissues (Kubera 2001; Silberman, Wald, and Genaro 2002;
Wang, Shi, and Denhardt 2007) and decreases in organ mass (Dhabhar and
McEwen 1999; Seyle 1998). Spaceflight studies on astronauts have also shown
a link between increase in stress hormones and Ebstein-Barr reactivation
(Pierson et al. 2005).
Splenic WBC and leukocyte subpopulation counts were also significantly
reduced after flight. A decrease in granulocyte count is consistent with our
previous study (Pecaut et al. 2003), and similar results were found after STS-57
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using a rat model (Grove, Pishak, and Mastro 1995). However, there were no
significant differences in splenic leukocytes after a shorter, 9-day flight (Allebban
et al. 1994), suggesting that flight duration may be a critical factor. These losses
likely reflect changes in leukocyte trafficking patterns due to flight-induced
muscle atrophy (Pecaut, Simske, and Fleshner 2000), changes in fluid volume
and distribution (Nash et al. 1992), and/or stress. Ground-based studies have
already shown that stress can result in splenocyte apoptosis (Wang, Shi, and
Denhardt 2007).
To determine the recovery and proliferative capacity of lymphocytes, we
characterized spontaneous blastogenesis. The observed increase in [3H]-TdR
incorporation by splenic lymphocytes demonstrates that ex vivo DNA synthesis
was increased after flight and suggests that the cells were capable of shifting to a
proliferative (or recovery) state once removed from any stress-induced inhibition
in vivo. In contrast, LPS-induced proliferation was decreased in the flight mice
indicating that the ability to respond to a potent B cell mitogen may be
compromised. There has been at least one study where investigators reported
increases in the LPS response (Nash et al. 1992), suggesting that this response
may be dependent on the animal model. Interestingly, decreases in the response
to T cell mitogens (PHA and Con A) have consistently been reported (Mandel
and Balish 1977; Nash et al. 1992; Sonnenfeld et al. 1998). This, combined with
our results, would suggest that although there is an increase overall proliferative
capacity, there is a down-regulation of adaptive immune mechanisms. However,
further studies are required to confirm this down-regulation.
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Ex vivo cytokine production has been shown to alter during and post flight
in cells obtained from mice, rats, non-human primates, astronauts and
cosmonauts (Chapes et al. 1992; Gould et al. 1987; Gridley et al. 2003;
Sonnenfeld 2001b). Cytokine concentrations in the extracellular milieu dictate
proliferation and activity of immunocytes, as well as numerous other cell types. In
the present study, LPS was used for activation of splenocytes that consisted of a
mixture of leukocytes. Although LPS is often referred to as a B cell mitogen,
interactions among B cells, T cells and macrophages are inevitable in a cellular
mixture.
IL-6 is a cytokine with both pro- and anti-inflammatory effects that is
typically secreted by T cells and macrophages. Its ability to induce TNF-oc and IL1p antagonists indicate that it is a major factor needed for resolution of
inflammation and the switch from innate to adaptive immunity (Jones 2005).
Recent reports indicate that IL-6 is also released by contracting muscles
(Febbraio and Pedersen 2005; Pederson et al. 2005), suggesting that the
secretion of this cytokine may be influenced by the post-flight muscle tests.
Furthermore, muscle atrophy can result in inflammation, leading to increase in
presence of phagocytic cells, and hence an increase in IL-6 levels. Another,
albeit unlikely possibility, is that the smooth muscle of blood vessels within the
spleen may be secreting IL-6. However, IL-6 levels in this study were quantified
ex-vivo and any cytokines present in the spleen and/or circulation were likely
washed away in the splenocyte processing procedure prior to stimulation. As IL-6
is also associated with increases in IL-10 and other anti-inflammatory cytokines
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in the presence of stress and an immune challenge (DeRijk et al. 1997; Hawkly
et al. 2007; Xing et al. 1998), we believe our changes in secretion are due to
persistently activated anti-inflammatory mechanisms induced by spaceflightrelated stress.
IL-10, produced by macrophages and to a lesser extent also Th2 cells
inhibits adaptive immunity by down-regulating Th1 cytokine expression, MHC II
molecules and co-stimulatory proteins on ARC (Moore et al. 2001). However, the
ultimate effect of both IL-6 and IL-10 is to limit inflammation (Hawkly et al. 2007).
In contrast, TNF-a is a potent pro-inflammatory cytokine secreted primarily by
macrophages (Locksley, Killeen, and Lenardo 2001). The increased capacity to
produce IL-6 and IL-10 seen in the present study, coupled with the low level of
TNF-pc and the absence of any change in IL-1p , suggests an overall decrease in
inflammatory mechanisms. In our previous study on STS-108, we found an
increase in PHA-induced pro-inflammatory cytokines TNF-a and IL-2 (Gridley et
al. 2003). As PHA stimulates T cells, this apparent discrepancy is likely due to
differences in the target populations of the mitogen. Further research is required
to determine if this mitogen-dependent difference in responses is due to a
spaceflight-induced shift away from B cell to T cell mechanisms.
Perhaps not surprisingly, there are ground-based studies, which suggest
that these differences in cytokine production may be attributed to a stress
response. For instance, ACTH and catecholamines have both been shown to
influence cytokine production in the presence of LPS (Kitamura 2007).
Glucocorticoids and catecholamines regulate Th2 cytokine production via
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stimulation of the glucocorticoid receptors and p2AR. Through the stimulation of
P2AR, catecholamines up-regulate production of anti-inflammatory cytokines, IL-6
and IL-10 (Elenkov 2008; Hasko et al. 1995; Maimone et al. 1993), leading to a
decrease in TNF-a levels (Batistaki et al. 2008).
An important aspect of spaceflight is the production of ROS as they play
vital roles in cell signaling, mitogen response, cell differentiation and apoptosis.
Furthermore, sustained exposure to high concentrations of ROS can lead to
tumorigenesis, diabetes and sepsis (Georgieva 2005; Poll et al. 2004). Increases
in lipid peroxidation of human erythrocytes and reductions in circulating
antioxidant levels after long-duration spaceflights have been reported (Stein
2002). Using the hindlimb suspension (HS) model, Guillot et al. (2008) (Guillot et
al. 2008) found that HS may alter ROS metabolism and Fleming et al. (1991)
(Fleming, Edelman, and Chapes 1991) reported an increase in superoxide
responses by murine polymorphonuclear neutrophilic leukocyte (PMNs) when
exposed to short periods of microgravity. Exposure to chronic stress has also
been reported to chronically increase ROS production and oxidative stress
(Stojiljkovic et al. 2005).
These previously published findings are consistent with our liver gene
expression data obtained from the liver. We found that many of the genes
responsible for scavenging ROS were up-regulated. These genes included
Fmo2, involved in ROS metabolism, and peroxidases such as glutathione
peroxidase 6 and cytoglobin. Cytoglobin is also responsible for intracellular
oxygen storage and transfer and sensing of 02. By far, we saw the greatest
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increase in myoglobin transcript, an important ROS transporter. The upregulation of these genes in the FLT mice can be attributed to cells attempting to
scavenge excess ROS. These changes may also be a result of re-adaptation to
nominal G rather than an actual space-flight effect. Although the majority of the
genes responsible for ROS scavenging were up-regulated, several genes,
involved in ROS production were also up-regulated. For instance, we found an
increase in a gene in the NADPH oxidase complex, Nox 1. However, this gene
has been shown to be involved in normal cell metabolism, including cell
proliferation (Lambeth 2004). The elevation of Nox1 in the liver of FLT mice may
be due to an increase in proliferation consistent with our splenic blastogenesis
results. This, in turn, could be due to a stress-induced decrease in liver mass, in
combination with an increased demand for hepatocytes involved with clearing
dead/dying cell debris from the blood (Gao, Jeong, and Tian 2008). Nox4
expression, on the other hand decreased. This homolog of Nox1 has been
shown to be elevated in response to hypoxia (Leto and Geiszt 2006), and studies
have suggested that microgravity and spaceflight lead to hypoxia (Lowry 1961;
Frisk, Elliott, and West 2000; Sausen et al. 2003).
The data confirm that immune parameters are influenced by the
spaceflight environment. The results suggest that the stressors inherent to
spaceflight missions lead to a shift toward anti-inflammatory responses shortly
after landing. The up-regulation in ROS scavenging genes, suppression of LPSinduced blastogenesis, and changes in the cytokine expression profile all indicate
an overall activation of anti-inflammatory signaling. This shift may very well be
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necessary to regain homeostasis upon return to Earth. Furthermore, these data
also suggest that the response to an infection with Gram-negative bacteria may
be compromised during the time needed to regain homeostasis. However, further
research is necessary to verify this possibility (e.g. characterize changes in TLR4
expression) (Leendertse et al. 2008; Oliveira et al. 2008).
It remains to be determined whether homeostasis can be efficiently
achieved after chronic stress exposure experienced during extended journeys in
space. Recent reports (Carrero et al. 2008) suggest that inflammation is, indeed
associated with muscle atrophy. This would be consistent with our changes in
liver gene expression patterns. It is quite possible that long-term exposures to the
spaceflight environment may lead to an increase in the prevalence of chronic
inflammatory disease. However, this idea is speculative and, to the best of our
knowledge, has not yet been considered in the context of space flight. As long
duration missions are being planned, it is important to better understand the
mechanisms responsible for the observed changes in the immune parameters in
order to reduce health risks to astronauts.
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CHAPTER THREE
EFFECTS OF WHOLE-BODY PROTON RADIATION ON
PHAGOCYTIC FUNCTION
Introduction
Previous studies have shown that radiation has an effect on the immune
response, immune cell numbers and inflammatory cytokine expression.
Radiation-induced changes in the cytokine response to an in vivo immune
challenge could have a great impact on the role HPA/SNS activity plays in
maintaining homeostasis. In this study, we characterized the effects of proton
radiation on key aspects of host defense against a live pathogen, focusing
specifically on phagocytic function. Upon recognition of a pathogen, phagocytic
cells (e.g. macrophages) release a cascade of cytokines, including IL-1, TNF-a
IL-6 and IFN-y, as well as a variety of ROS. These initial responses not only
activate surrounding immune populations, but also stimulate the HPA and SNS
pathways, ensuring a coordinated, systemic response. Should the infection
persist, macrophages are also able to present the fragments of the pathogen (i.e.
peptides of the antigen) to CD4+ Th cells via MHC II, thereby triggering
additional, adaptive responses.
In this study, female 8-9 week old C57BL/6 mice were exposed to 3 Gy
(n=100) whole-body proton radiation or 0 Gy (n=100). Female mice were used
as they are less aggressive than male mice allowing long-term group housing
thereby minimizing stress associated with social isolation. One, 2, 4, 8 and 16
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days post-radiation, mice received 5x107 colony forming units (CFU) of E. coli or
phosphate buffer solution (PBS) via i.p. injection (n=10/grp). These time points
were chosen as an optimum response was expected to be seen within the time
points. The majority of non-radiation related studies investigating effects of the
immune response typically include the use of LPS (Gram-negative bacteria
endotoxin). This however, does not mimic a naturally occurring live infection.
Hence, we selected a live E. coli challenge to elicit an immune response. One
hour post-inoculation, mice were sacrificed with 100% C02. After a peritoneal
lavage with ice cold PBS, blood was collected via cardiac puncture. Brains were
removed and fixed in 4% paraformaldehyde (PFA). Brain tissues were analyzed
for changes in cFos-like immunoreactivity in the PVN. Spleen and liver were
harvested and processed. Leukocyte counts in blood, liver and spleen were
obtained. Spleen supernatant was used for determining changes in levels of
cytokine production. Splenocytes and hepatocytes were used to characterize
phagocytic activity and the capacity to generate an oxidative burst. Splenocytes
were also used to determine changes in MHC II expression. The blood and
peritoneal lavage were used to determine the ability of the immune system to
clear the injected E. coli.

Materials and Methods
Animals
Female C57BL/6 mice (n=200) were purchased from Charles River
Breeding Laboratories, Inc (Hollister, CA) at 8-9 weeks of age and shipped
directly to Loma Linda University Animal Care Facility. The animals were
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acclimatized for 1-2 weeks before study initiation. The animals were maintained
in a room controlled for temperature, humidity, and a 12:12 hr light dark cycle;
food and water were available ad libitum. All protocols involving animals were
approved by the IACUC of Loma Linda University.

Whole -Body Irradiation
Immediately before irradiation, unanesthetized mice (test and shamirradiated) were placed into a rectangular plastic box (30 x 30 x 60 mm3) with air
holes. Mice were in these boxes for a maximum of 10 minutes. A maximum of 6
mice were irradiated simultaneously within a 20 x 20 cm field (~0.7 Gy/min, 250
MeV, entry region of Bragg curve) using a modulated fixed horizontal beam at
the Loma Linda University proton synchrotron accelerator. Protons were
delivered in 0.3s pulses every 2.2s. Mice were irradiated behind a 400 x 400
mm2 polystyrene phantom. Dose calibration was performed using a Markus
parallel plate ionization chamber, as approved by the National Institute of
Standards and Technology (NIST). The International Commission on Radiation
Units (ICRU) 59 calibration method was used to convert the ionization signal to
dose in water. The dose was delivered in a single fraction to 3 Gy. After
irradiation, mice were returned to cages and were observed until they resumed
normal posture and behavior.

E. coli Propagation and Inoculation
To obtain large numbers of E. coli tor injection into mice, 100 to 500 ml of
tryptic soy broth from a fresh plate of E. coli (0111 :B5) (American Type Culture
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Collection, Rockville, MD) was inoculated using a sterile loop, and incubate
overnight at 37°C. After incubation, the culture was diluted to an optical density
reading of 0.011 (570 nm spectrophotometer setting) for an approximate
concentration of 108 organisms/ml. The desired bacterial concentration was
obtained by using fresh tryptic soy broth for dilution. In brief, CFU/ml were titrated
in serial 10-fold dilutions of the bacterial suspension. A series of dilutions were
made from 10"6 through 10'1 organisms/ml. From each bacterial dilution tube, 0.1
ml was removed and streaked onto a sterile tryptic soy agar plate using a sterile
loop and were incubated overnight at 37°C. After incubation, the culture was
diluted to an optical density of 0.011 at a spectrophotometer setting of 570 nm in
order to obtain approximately 108 organisms/mL. The bacteria were diluted from
1x10"6 to 1x10'1 and 0.1 ml aliquots from each dilution were streaked on a sterile
tryptic soy agar plates and were incubated overnight at 37°C. Colonies were
adjusted the following day to 5x 107 CFU. Calculation were done using the
formula CFU/ml_=colonies counted/ (dilution x volume). E. coli \n PBS was
administered to mice via i.p. injection.

Euthanasia
Animals were euthanized with 100% C02 (Pecaut et al. 2000) at each time
point of study.
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Peritoneal Lavage
To determine clearance in the peritoneal cavity, 10 mL of ice cold PBS
was injected into the peritoneum. The PBS was then extracted with a syringe and
lavage was kept on ice until analysis.

Blood Collection
Approximately 0.5ml whole blood was collected in [K2]EDTA by cardiac
puncture using a 26 G 3/8“ syringe at the time of euthanasia. Approximately 30
jiL

of EDTA was used.

Preparation of Hepatocytes and Splenocytes
Each spleen was placed in 2mL of RPMI 140 medium supplemented with
5% fetal calf serum (PCS). Splenocytes were dissociated using sterile wooden
sticks and passed the cells through a nylon mesh (40 jum). Cells were washed
once and red blood cells were lysed using a lysis buffer containing potassium
bicarbonate, ammonium chloride and tetra EDTA. Cells were washed twice and
were then resuspended in tissue culture medium consisting of RPMI 1640
supplemented with 10% PCS, 2 mM L-glutamine, 50 mg/mL gentamicin, 1mM
nonessential amino acids, 1mM sodium pyruvate, 10 mg/mL adenosine, uridine,
cytosine and guanosine and 0.05 mM 2-mercaptoethanol.
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Cell Counts
Whole blood and splenic leukocyte counts were evaluated using the ABC
Vet Hematology Analyzer (Heska Corp., Waukesha, Wl). Measurements
included WBC counts and 3-part differential.

Cytokine Quantification
Cell suspensions from the spleen were centrifuged and the supernatant
was used for quantification of TNF-a, IL-1(3, IL-6and IL-10, using Quantikine
ELISA kits (R&D Systems), according to the manufacturer’s instruction. Each kit
included standards, control and pre-coated plates with monoclonal/polyclonal
antibodies. Briefly, standards, control and samples were pipetted into the
appropriate wells. Cytokines bind to the immobilized antibody on the pre-coated
plates. After incubation, unbound substances were washed away and a substrate
solution was added for color product development and then the reaction was
stopped upon addition of a stop solution. The absorbance was read using a plate
reader (Infinite M200, Tecan, Durham, NC) at an absorbance of 450 nm. The
minimum detectable dose for TNF-a, IL-1p, IL-6 and IL-10 are 5.1 pg/mL, 3.0
pg/mL, 1.6 pg/mL and 4.0 pg/mL respectively.

Phagocytosis
Phagocytic activity in both liver and spleen was measured using the
Vybrant® Phagocytosis Assay Kit (V-6694, Molecular Probes, Inc., Eugene, OR)
according to the manufacturer’s instructions. Fluorescein isothiocyanate (FITC)labeled E. co//K-12 BioParticles were added to splenocyte and liver
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suspensions. After a 2-hour incubation period, the proportion of macrophages
involved in phagocytic activity were assessed via flow cytometry (4-color
FACSCalibur™ flow cytometer, Becton Dickinson, Inc., San Jose, CA).

Oxidative Burst and ROS Activity
The level of oxygen radical production by phagocytes was evaluated using
portions of spleen and liver as previously described (Wan, Myung, and Lau
1993). In this assay, 2’,7’-dichloro-dihydrofluorescein diacetate (DCFH-DA;
Molecular Probes, Inc.), a membrane permeant diacetate derivative of DCFH
was used as a probe. Both DCFH-DA and DCFH are non-fluorescent fluorescein
analogues that are oxidized to highly fluorescent 2’,7’-dichlorofluorescein (DCF)
by H2O2 and hydroperoxides. Zymosan A (Sigma) from yeast cell wall
(Saccharomyces cerevisiae) were used as a triggering agent. Cells were plated
into wells of 96-microwell plates at a concentration of 2.5 x 106/well/0.1mL and
were incubated for 1 hr at 37°C in 5% C02. DCFH-DA/Zymosan working solution
(150 mM DCFH-DA in 20 mg zymosan/ ml Hanks Salt Solution) was then added
at 10 pl/well and the plates were re-incubated for 1 hour (37°C, 5% C02). The
fluorescence intensity (relative fluorescence unit, RFU) was measured using a
fluorometer at 490 nm excitation and 530 nm emission.

MHC II Expression
Phagocyte MHC II in the spleen was determined with a 4-color
FACSCalibur flow cytometer (BD, Franklin Lakes, NJ). Monocolonal antibodies
labeled with fluorescein isothicanate (FITC), R-phycoerythrin (PE), or
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allophycocyanin (PC) were used to identify specific markers on mononuclear cell
populations. Data was collected on all events untill 10,000 cells were counted in
a CD45 (clone 30-F11) versus side scatter mononuclear cell gate.

cFos Immunohistochemistry
Brains were kept in vials containing 4% PFA and 2 g/ L of picric acid
solution overnight. As animals were not perfused at time of sacrifice, using picric
acid allowed better fixation of the brain. The brains were then incubated in 30%
sucrose in PBS solution overnight. Thereafter, brains were washed 3x in PBS
and embedded in optimum cutting temperature (OCT) embedding compound
(Electron Microscopy Sciences, Hatfield, PA) and frozen at -80°C. Using a
cryostat, brains were sectioned into 30 micron sections and placed in
cryoprotectant solution consisting of 100 ml glycerol, 120 ml_ ethylene glycol and
180 mL 0.5 M phosphate buffer solution at pH 7.2. Sections were washed 3x in
PBS, 10 minutes per wash and were placed in 10% normal goat serum (NGS)
and incubated for 30 minutes. Sections were transferred to sieves containing
antibodies specific for cFos (rabbit) (1:5000 Abeam, Cambridge, MA) overnight at
4°C. Sections were washed 3x with PBS and placed in 10% NGS for 30 minutes
followed by a 90 minute incubation in secondary antibody (rabbit) (Abeam
Cambridge, MA). Sections were washed in PBS for 10 minutes followed by a 25
minute incubation in a methanol bleach solution containing 5 mL methanol, 8.32
mL 30% hydrogen peroxide and 85.2 mL 0.15 M sodium phosphate buffer at pH
7.2. After 3 PBS washes, sections were incubated in ABC (1:600 Vectasatain
ABC kit, Vector Laboratories, Burlingame, CA) solution for 90 minutes. After 2
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PBS washes, sections were incubated in 0.1 M acetate imidazole buffer at pH
7.4, followed by a 4-5 minute incubation in 3,3'-Diaminobenzidine (DAB) (ACROS
Organics, New Jersey) solution containing 3 g nickel sulfate, 20 mg of DAB, 600
pL of 1% H2O2 and 120 ml of 0.1 M acetate imidazole buffer. Sections were
washed in 1x acetate imidazole buffer and 2x PBS and refrigerated overnight and
placed on glass slide the following day. Samples were then dehydrated.
Dehydration was obtained by a 30s wash in H20, 1 minute wash in 70% ethanol,
2x 1 minute washes in 95% ethanol, 1 minute wash in 100% ethanol followed by
a 3 minute wash in 100% ethanol. Slides were washed 2x in Histoclear (VWR,
Pennsylvania) followed by a 5-minute wash in Histoclear. cFos stains were
quantified using Image-Pro software (Media Cybernetics, Bethesda, MD).

E. coli Clearance
At each time point post-infection, clearance of E. coli was done on the
peritoneal lavage and blood. A series of 1:10 dilutions were prepared and 50 pL
of each dilution was spread on MacConkey’s selective agar. After a 24-hour
incubation, the colonies were counted using a colony counter (Colcount, Oxform
Optronix, Oxford, UK).

Statistical Analysis
Data were analyzed with analysis of variance (ANOVA) (SPSS Inc. Chicago, IL).
Tukey’s test was performed for pair-wise multiple comparisons. P values of <0.05
and <0.1 were selected to indicate significance and trend, respectively.
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Results
Spleen Mass
There was a significant decrease in total spleen mass due to radiation
(p<0.001) (Fig. 10). Significant E. coli (p<0.05) and day (p<0.001) effects, and a
radiation x day interaction (p<0.001) were also noted.

Leukocyte Subpopulations in the Blood
As shown in Fig. 11, there were significant E. coli effects on total WBC
(p<0.05), lymphocytes and monocytes counts, as well as on percent monocytes
(ps<0.001). There were also main effects of day on lymphocytes, monocytes and
granulocytes (p<0.001, p<0.005 and p<0.001, respectively), and on the
percentages of lymphocytes, monocytes and granulocytes (ps<0.001).
More importantly, there were significant decreases due to radiation in total
WBC, lymphocyte, monocyte and granulocyte counts (p<0.001). There were also
significant radiation effects on the proportions of lymphocytes, monocytes and
granulocytes (p<0.001) (Fig. 12). The percentages of lymphocytes were reduced;
whereas the percentage of monocytes was increased due to radiation.
There were radiation x E. coli interactions in the total WBC (p<0.05)
lymphocytes p<0.005) and monocytes (p<0.001), and a similar trend in
percentage of monocytes (p=0.085). Finally, there were radiation x day
interactions on lymphocyte and monocyte counts, as well as on the proportions
of all three major leukocyte populations (p<0.001). Generally, the effects of
radiation were greatest on day 2. However, while there appears to be a recovery
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in all populations by day 16 in terms of percentages; counts were still lower in
irradiated mice compared to control groups.
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Leukocyte Subpopulations in the Spleen
A significant E. co//effect was present for the percentage of monocytes
(Fig. 13). A main effect of day was observed in lymphocytes, monocytes and
granulocytes and their percentages (p<0.001). There were significant decreases
due to radiation (p<0.001) in total WBC, lymphocytes, monocytes and
granulocytes, as well as in their respective percentages (Fig. 14).
A significant interaction of E. colix radiation was also observed in overall
WBC, lymphocytes, monocytes and granulocytes (p<0.001) (Fig. 13), in addition
to the percentage of lymphocytes (p<0.05) and granulocytes (p<0.05) (Fig. 14).
Finally, there were significant effect (Fig. 13) (p<0.001) of radiation x day
interactions in total WBC, all subpopulations and proportions (Fig. 14). Leukocyte
counts were generally lowest on day 2, returning to control levels by day 16 (Fig.
13). In contrast, the proportion of lymphocytes increased by day 2 and decreased
by day 8. The percentages of lymphocytes returned to control levels levels by
day 16. Percentage of monocytes and granulocytes on the other hand decreased
on day 2 and increased by day 8. These levels returned to control levels by day
16.
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Cytokine Levels in Spleen Supernatants
A significant E .co//effect was present for TNF-a, IL-1p, IL-6 and IL-10
(p<0.001) (Fig. 15). There were also main effects of day on IL-tp and IL-10
(p<0.001). Radiation had a significant effect on TNF-a, (p<0.005), IL-ip (p<0.01)
and IL-6 (p<0.05). Typically, concentrations of these cytokines were not
quantifiable in unchallenged mice. However, E. co//-induced increases in TNF-a
and IL-6 levels, effects that were further enhanced by radiation. In contrast
radiation generally suppressed the E. co//-induced increases in IL-1p secretion.
Together, these responses resulted in significant E. colix radiation interaction on
all TNF-a, IL-ip, IL-6 and IL-10 levels (p< 0.001, p<0.05, p<0.05 and p<0.05,
respectively).
The change in level of IL-1 p appears to be transient as radiation-induced
decrement in the E. co//-induced response were noted only at the early time
points (Post Hoc Tukeys: p<0.05 for days 1 and 2, p<0.005 for day 4).
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Phagocytic Activity
There was a significant radiation effect on phagocytic activity in both the
spleen and the liver (Fig. 16) (p<0.001 and p<0.05, respectively), indicating an
overall increase in phagocytic activity in these two organs. Both spleen and liver
had main effects of day and radiation x day interactions (ps<0.05).

Oxidative Burst Activity
There was a significant radiation effect on ROS production in the spleen
(p< 0.001). Although there was no main effect of radiation on liver oxidative burst
activity, there was a significant increase in ROS at 2 days post-irradiation. A main
effect of day was observed in both spleen and liver with a day x radiation
interaction (p<0.001) in the spleen (Fig. 17).
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Bacteria Clearance
There was a significant radiation effect (p<0.05) on efficiency of clearance
in the blood, however, there were no significant changes on bacterial clearance
in the peritoneal lavage. There was a main effect of day (p<0.001) in the
peritoneal lavage (Fig. 18).

MHC II Expression
Significant radiation (p<0.001) and day (p<0.001) effects were observed
on MHC II expression in splenocytes (Fig. 19). MHC II expression increased at
early time points and returned back to normal by day 16. An E. colix radiation
interaction (p<0.001) was observed. Although there were no significant E. coliinduced changes in MHC II expression, a trend was observed (p=0.063).
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Immunostaining for cFos Protein Expression
Although there was no main effect of E. coli, there was a significant
radiation (p<0.05) and day (p< 0.001) effect on cFos counts in the PVN (Fig. 20).
cFos expression was increased on day 16, however there were no changes in
the earlier time points of 1,2, 4 and 8 days post-irradiation.

87

3.0 -

2.5 -

2.0 V)

c
3
o

O

1.5 -

1.0 -

0.5 T

0

2

T

4

6

8

10

12

14

16

Days

Figure 20. Effects of proton radiation cFos counts in the PVN.
Values represent mean ± SEM. N=4/group/time point. *p<0.001
for main radiation effect, tp<0.05 for main day effect.

88

Discussion
Protons, which have a relatively low-LET (Kajioka et al. 2000) are ionizing
and hence they are able to cause damage to cells via free radical formation
breakage of chemical bonds, and DNA damage. As actively dividing cells
particularly leukocyte populations, are sensitive to radiation-induced DNA
damage, it is not surprising that whole-body exposure to protons resulted in
significant decreases in circulating and splenic WBC counts. This is consistent
with previously reported results using x-, y- and proton irradiation (Gridley,
Andres, and Slater 1997; Harrington et al. 1997; Hsu et al. 1996; Kajioka et al.
2000). In both compartments, the nadir of radiation effects appears to be around
2 days post-exposure. As radiation causes DNA damage, there is not only a
delay in cell proliferation, but also a further decrease in overall cell counts due to
cell death. By day 4, cell counts begin to increase suggesting that radiation
induced-damage to leukocyte populations has stabilized, allowing an increase in
DNA synthesis and regeneration of cells. This is consistent with previous
investigations using proton radiation, which show an increase in [3H]-TdR
incorporation by day 4, indicating an increase in leukocyte proliferative capacity
(Pecaut et al. 2002). By day 16, leukocyte counts in the spleen regenerated to
normal levels. In contrast, blood leukocyte counts were still lower than control
groups 16 days post-irradiation. This is consistent with previous studies done on
long-term effects of proton radiation on immunity, where it has been shown
peripheral WBC counts were still depressed 122 days post irradiation (Pecaut,
Gridley, and Nelson 2003). This chronic effect of radiation on circulating
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populations may reflect a change in population homeostasis and/or a continued
recruitment of leukocyte populations out of the blood into peripheral tissues due
to long-term systemic damage. However, as we did not characterize non-immune
tissues for signs of apoptosis or necrosis, this idea is speculative, at best.
Significant decreases in lymphocyte percentages in both blood and
spleen, in addition to significant increases in the proportions of monocytes and
granulocytes in the irradiated groups was noted. The increased radiosensitivity of
lymphocytes compared to monocytes in both spleen and blood is consistent with
previous reports. Studies have shown that monocyte-macrophages are
consistently less radio-susceptible than lymphocytes, regardless of the tissue,
including bone marrow, lymph nodes and peritoneal cavity (Gridley, Pecaut, and
Nelson 2002). This increase also indicates increased trafficking of monocytes
and granulocytes to damaged regions caused by radiation, as these cells are
highly phagocytic in function and hence scavenge cellular debris.
Cells of the innate immune system, macrophages in particular, respond to
infection or injury by shifting from a resting to an active state. The activated
phenotype is defined by a range of cytotoxic effector functions including the
release of inflammatory cytokines (McKinney et al. 1998). Increases in splenic
levels of inflammatory cytokines IL-1p, TNF-a and IL-6 were found in both
irradiated and non-irradiated groups when mice were exposed to live E. coli.
However, there were even higher levels of TNF-a and IL-6 in the irradiated
groups. The increases in these cytokines are consistent with previous studies
reporting radiation-induced increases in proinflammatory cytokines (Linard et al.

90

2004; McKinney et al. 1998), and likely reflect an activation of innate responses
due to radiation-induced tissue damage.
Apart from being communicators of the immune, these cytokines can also
facilitate recovery from such damage via activation of signal transduction
systems. Consistent with this idea are reports that whole-body exposure to
ionizing radiation can result in significant increases in circulating granulocytemacrophage colony stimulating factor (GM-CSF), a cytokine known to prime cells
for the release of pro inflammatory cytokines (Brissette et al. 1995). GM-CSF
secretion can lead to increases in circulating macrophage and granulocyte
counts by stimulating hematopoiesis, potentially counteracting radiation-induced
cell loss and facilitating the removal of debris due to damaged or dead tissue.
Therefore, increases in these cytokines not only indicate an increase in
inflammatory activity, but also in the activity of mechanisms responsible for
cellular regeneration. This is consistent with our results where leukocyte counts
in the spleen returned to control levels by 16 days post-irradiation.
Surprisingly, IL-1p secretion was significantly lower in irradiated,
compared to non-irradiated, E. co//-treated groups at the early time points. As this
cytokine is highly proinflammatory, we expected an increase in the irradiated E.
co//-treated group. Generally, IL-1p secretion corresponds very well with TNF-oc
and IL-6. The discrepancy may be attributed to the source of the cytokine. IL-1p
is released not only by macrophages, but also B cells and dendritic cells.
Although not characterized here, previous reports indicate that B cells are highly
radiosensitive compared to macrophages (Gridley, Pecaut, and Nelson 2002).
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Hence, the early decreases in total splenic IL-1p may be due to overall
decreases in splenic B cell populations.
Radiation has been shown to increase ROS due, at least in part, to
ionization of water molecules in cells. These ROS have been linked to increase
in activation of NF-kB, which plays a pivotal role in the inducible expression of
inflammatory cytokines (Linard et al. 2004). ROS mediate NF-kB activity through
Ca2+-dependent and PKC-dependent cytoplasmic signaling pathways. Studies
have shown that by inhibiting PKC, radiation-induced increases in IL-1 and IL-6
are abrogated (Hosoi et al. 2001). Therefore, radiation-induced increases in
these inflammatory cytokines may be linked to ROS and subsequent NF-kB
activation.
The level of IL-10, an anti-inflammatory cytokine, was increased in both
non-irradiated and irradiated groups treated with E. coli. IL-10 is highly
immunosuppressive and is released in response of high levels of inflammatory
cytokines. Thus, the increase in the IL-10 levels can be attributed to the high
levels of inflammatory cytokines released in response to E. co//treatment. Like
IL-ip, radiation appears to impact IL-10 at the early time points. However, unlike
IL-1p, radiation appears to enhance the E. co//-induced increase in IL-10. This
suggests that the effects of radiation on this parameter are minimal and, at best
transient under conditions of the present study.
An important function of the innate immune response is to phagocytose
foreign materials including pathogenic microbes. An overall radiation-induced
increase in phagocytic activity of leukocytes in spleen was observed. This is
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consistent with previous studies using y- and x-rays (Conrad, Ritter, and Nixdorff
; Lorimore et al. 2001). Apoptotic cell death is common after exposure to ionizing
radiation (Conrad, Ritter, and Nixdorff) and leads to the upregulation of innate
immune activity, which includes phagocytosis. It has been reported that radiation
results in priming of macrophages into an activated state (Lambert and Paulnock
1987). Therefore, the observed overall increase in phagocytic function in the liver
and spleen could be due to a priming effect of radiation on macrophages.
Although radiation generally increased phagocytic activity in both the
spleen and the liver, there also appears to be a temporal component to the
response. Specifically, there was a significant decrease in phagocytic activity on
day 1 in the spleen, with a similar decrease on day 2 in the liver. These transient
responses may be linked to the acute handling stress during set-up for
irradiation. Studies have shown that stress can lead to increases in glucocorticoid
and catecholamine levels, which are known to be immunosuppressive, hence
decreasing innate immune response. It has also been shown that physical stress
can lead to increases in NO levels via inducible NO synthase (iNOS) in
macrophages as a result of increase in phagocytic activity (Turner et al. 2005).
Ingestion of particles by phagocytic cells can trigger the release of
unstable oxygen species, NO, and degradative enzymes. With the overall
radiation-induced increase in inflammatory cytokine release and phagocytic
activity, an overall increase in the generation of ROS is not surprising.
Investigators using y-radiation have reported increases in lysosomal and NOS
enzyme activity (Lorimore et al. 2001), as well as NO and ROS production (Gallin
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and Green 1987; Ibuki and Goto 2000; Pandey et al. 2005). It is also believed
that this is due to radiation-induced increase in the activation of PKC (Ibuki and
Goto 2000). Low-dose proton radiation also results in increases in leukocyte
ROS generation (Gallin and Green 1987). The changes reported here indicate
that proton radiation enhances the ability of leukocytes to generate ROS when
stimulated with zymosan. This, in turn, suggests that exposure to low-dose
radiation may lead to chronic inflammation and tissue damage.
The most important function of the innate immune response is to eliminate
infectious agents with potential to cause disease. Radiation did not have a
statistically significant effect on bacterial clearance in the peritoneal cavity.
However, radiation did appear to improve clearance efficiency in the blood,
particularly at the later time points. Peritoneal macrophages play an important
role in clearing bacteria in the peritoneal cavity and the lack of differences in the
clearance of bacterial between the irradiated and non-irradiated groups suggests
that peritoneal macrophages in the irradiated groups are functioning properly.
The late radiation-induced increases in blood clearance rates suggests that
exposure to radiation causes a long-term shift in monocyte/macrophage activity;
a shift in neutrophil activity must also be considered, since there are by far the
most abundant phagocytic cell type in the blood, likely including both
monocyte/macrophage and neutrophil populations. As there were no chronic
effects of radiation on phagocytic or oxidative burst activity in the liver and
spleen, this effect is difficult to explain. One possibility is that the functional
capacity of circulating monocyte/macrophages and neutrophils differs from that of
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the liver and spleen. Furthermore, populations in the blood are particularly
sensitive to changes in the bone marrow. It is possible that ionizing radiation
induced a long-term change in hematopoiesis, resulting in a shift in circulating
monocyte and/or neutrophil populations. Changes in hematopoiesis would be
consistent with the long-term decreases in overall circulating leukocyte counts
and the differences in numerical and proportional values seen in some
populations. Also, since the level of phagocyte responsiveness is not identical
against all particulate materials, another factor to consider is the use of different
triggering agents for the functional assessments in the three body compartments
(E. coli 0111 :B5 for bacterial clearance in blood, E. coli K-12 for phagocytosis in
liver and spleen and a preparation consisting of yeast wall for oxidative burst in
liver and spleen). Finally, dysregulation of positive/negative feedback
mechanisms that may involve cells responsible for adaptive immunity cannot be
excluded because a mixture of cell types was present in these assays.
Innate and adaptive immune responses are functionally linked through
antigen presentation by APCs to CD4+ Th cells via MHC II. Proton irradiation
caused an early, but transient increase in MHC II expressed on mononuclear
splenocytes. By 16 days post-irradiation, the early increases were no longer
present. Previous studies using y-radiation have also shown an increase in MHC
I / II expression post-treatment (Chiriva-lnternati et al. 2006; Reits et al. 2006).
However, the underlying mechanism is unknown. Studies have shown changes
in signal transduction pathways due to radiation, thus the radiation-induced
changes are possibly due to rapid-upregulation of genes required for MHC II
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expression. Endotoxins also result in an upregulation of MHC II molecules, which
is further enhanced by IFN-y, released by Th1 cells. Even though it has been
reported that radiation does induce increases in IFN-y release (Lugade et al.
2008; McKinney et al. 1998), macrophages can also inhibit IFN-y - dependent
induction of MHC II in response to LPS regardless of treatment with or without
radiation (Casals et al. 2007). This would explain the lack of an upregulation of
MHC II expression in our E. co//-treated groups. The lack of sustained
upregulation of this complex may also be due to the rapid clearance of the E.
coli. In the absence of a chronic infection the need for antigen presentation via
MHC II to T cells is diminished.
Increases in inflammatory cytokines in response to an innate immune
challenge typically leads to the activation of the HPA-axis. This bilateral
communication between the immune system and the CNS plays an essential role
in balancing the immune response and maintaining homeostasis. Upon the
release of inflammatory cytokines in the periphery, there is a marked increase in
cFos expression in the PVN of the hypothalamus. This is followed by increases in
circulating CRH levels, and eventually leads to the release of glucocorticoids
from the adrenal gland into the circulation. Although it has been reported that
whole-body y-radiation exposure leads to decrease in cFos mRNA in the whole
brain (Ogawa et al. 1996), we did not find any measurable radiation-induced
differences in cFos activity in PVN one hour post-inoculation. As E. co//itself did
not increase in measured cFos immunoreactivity in the PVN, we believe the lack
of a radiation effect is likely an issue of timing. Specifically, we believe that one-
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hour post-challenge is too soon to detect measureable levels of cFos activity in
the PVN.
In summary, the data show that whole body proton radiation results in
changes in leukocyte populations in both blood and the spleen. Even though the
populations in the spleen recover by 16 days post-irradiation, there is a long-term
effect of radiation on overall blood leukocyte counts as well as in the proportions
of some population subsets. Radiation also caused increases in inflammatory
cytokine levels in the spleen, phagocytic and oxidative burst activity in the spleen
and liver, and MHC II expression in splenocytes. These data indicate that proton
radiation can significantly impact innate immune responses in the context of
bacterial challenge.

97

CHAPTER FOUR
EFFECTS OF BODY-ONLY PROTON RADIATION ON PHAGOCYTIC
FUNCTION AND IMMUNE-NEURAL RESPONSE TO A LIVE PATHOGEN

Introduction
In the previous chapter, we established that whole-body proton irradiation
has an impact on several parameters of the immune system including leukocyte
population distributions, phagocytic activity, oxidative burst capacity, MHC II
expression and cytokine release. Furthermore, we established the time course of
events post-exposure. Most importantly, we demonstrated that radiation can
influence several aspects of the response to a live immune challenge. In keeping
with our overall hypothesis, we next sought to establish the effects of body-only
proton radiation on phagocytic activity and immune-neural responses. By
selectively avoiding exposure to the brain, we began to unravel the role played
by immune-CNS communication in radiation-induced changes in the response to
a live, in vivo challenge.
Immune-CNS communication is crucial in coordinating and regulating
immune-behavioral responses to a pathogenic challenge. Cytokines are critical in
communicating the presence of peripheral inflammatory events to the CNS and
their release is subsequently modulated by the activation of HPA/SNS pathways.
Activation of the HPA and SNS, which stimulate the release of glucocorticoids
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and catecholamines, respectively, typically down-regulates inflammatory
responses.
The brain autonomic centers and the immune system are linked
anatomically by a dense sympathetic innervation of lymphoid tissues such as the
spleen. Lymphocytes and macrophages have been shown to express adrenergic
receptors that bind with the catecholamines, NE and EPI. Upon receptor
stimulation of p2AR, there is an increase in intracellular cAMP, and a subsequent
change in cytokine expression patterns that ultimately leads to a shift away from
a pro-inflammatory response to one that is predominantly anti-inflammatory. We
believe that radiation can disrupt the homeostasis maintained by the immuneCNS communication.
In this study C57BL/6 mice, received 0 or 3 Gy body-only irradiation. To
minimize the direct effects of radiation on central neural tissues, we specifically
avoided radiation exposure to the head. Studies investigating the effects of the
immune response on HPA/SNS activation predominantly use of IPS (Gram
negative bacteria endotoxin) as antigen for immune activation. This however,
does not mimic a naturally occurring live infection. Hence, we selected a live E.
co//challenge to elicit an immune response. Eight days post-irradiation, mice
received 5x107 CPU of E. coli via i.p. injection. Ninety minutes post-inoculation,
the animals were sacrificed with 100% C02. Blood was collected via cardiac
puncture and plasma NE concentrations were obtained. Brains were removed
and fixed in 4% PFA. Brain tissue was analyzed for changes in cFos expression
in the PVN. Spleens were harvested to characterize NE and cytokine levels.
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Materials and Methods
Animals
Female C57BL/6 mice (n=36) were purchased from Charles River
(Hollister, CA) at 8-9 weeks of age and were shipped directly to Loma Linda
University Animal Care Facility. The animals were acclimatized for 1-2 weeks
before study initiation. The animals were maintained in a room controlled for
temperature, humidity, and a 12:12 hr light: dark cycle; food and water were
provided ad libitum. All protocols involving animals were approved by the Loma
Linda University IACUC.

Body-Only Irradiation
Each animal was anesthetized with isoflurane and was placed in positional
cradles to stabilize the head position during irradiation. The cradles were then
placed in a box designed for the beam line and 2% isoflurane gas was
administered until irradiation was complete. Two animals were irradiated
simultaneously. The body of each mouse was irradiated with protons (~0.7
Gy/min, 250 MeV, entry region of Bragg curve) at the Loma Linda University
proton synchrotron accelerator in a modulated fixed horizontal beam line. The
beam was collimated to 20 cm and a lead block was utilized to shield the heads.
Protons were delivered at 0.25 Gy/min. Mice were irradiated behind a 400 x 400
mm2 polystyrene phantom. Dose calibration was performed using a Pinpoint
ionization chamber (NIST traceable). The ICRU 59 calibration method was used
to convert the ionization signal to dose in water. Protons were delivered in a
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single fraction to total doses of 0 and 3 Gy. After the mice are irradiated, they
were observed until they resumed normal posture and behavior.

E. coli Propagation and Inoculation
To obtain large numbers of E. coli for injection into mice, 100 to 500 ml of
tryptic soy broth from a fresh plate of E. coli (0111 :B5), American Type Culture
Collection] were inoculated using a sterile loop, and incubated overnight at 37°C.
After incubation, the culture was diluted to an optical density reading of 0.011
(570 nm spectrophotometer setting) for an approximate concentration of 10 8
organisms/ml. This was diluted to the desired bacterial concentration using fresh
tryptic soy broth. Serial 10-fold dilution of the bacterial suspension was done to
titrate CFU/ml. A series of dilutions was made from 10'6 through 10'1
organisms/mL. From each bacterial dilution tube, 0.1 ml was removed and was
streaked onto a sterile tryptic soy agar (American Type Culture Collection) plate,
using a sterile loop and were incubated overnight at 37°C. After incubation, the
culture was diluted to an optical density of 0.011 at a spectrophotometer setting
of 570 nm in order to obtain approximately 108 organisms/mL. The bacteria were
diluted from 1x1 O'6 to 1x10'1 and 0.1 mL was streaked on a sterile tryptic soy agar
plate and incubated overnight at 37°C. Colonies were then adjusted the following
day to 5x107 CFU. This was calculated using the formula CFU/ml_=colonies
counted/(dilution x volume). E. coli ln PBS was administered to mice via i.p.
injection.
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Euthanasia
Animals were euthanized with 100% C02.

Blood Collection
Approximately 0.5 ml whole blood was collected in [K2]EDTA by cardiac
puncture using a 26 G 3/8“ syringe at the time of euthanasia. Approximately 30
jiL

of EDTA was used.

Preparation of Splenocytes
Each spleen was placed in 2 ml_ of RPMI 1640 medium supplemented
with 5% PCS. A cell suspension of splenocytes was obtained by passing the cells
through a nylon mesh (40 pm). Cells were washed once and red blood cells were
lysed using a lysing buffer. Cells were washed twice and then resuspended in
tissue culture medium consisting of RPMI 1640 supplemented with 10% PCS, 2
mM L-glutamine, 50 mg/mL gentamicin, 1 mM nonessential amino acids, 1 mM
sodium pyruvate, 10 mg/mL adenosine, uridine, cytosine and guanosine and
0.05 mM 2-mercaptoethanol.

Cell Counts
Spleens, processed into single-celled leukocyte suspensions as previously
described, were evaluated using the ABC Vet Hematology Analyzer (Heska
Corp., Waukesha, Wl). Measurements included WBC counts, 3-part differential
and other hematological parameters that are not directly related to this study.
The data obtained were normalized to spleen mass used in processing.
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Cytokine Quantification
Cells were centrifuged to remove debris and the supernatant were used
for quantification of TNF-oc, IL-1pJL-6 and IL-10 using Quantikine ELISA kits
(R&D Systems) according to the manufacturer’s instruction. Each kit included
standards, control and precoated plates with monoclonal/polyclonal antibodies.
Standards, control and samples were pipetted into the wells and the cytokines
were bound to the immobilized antibody. Unbound substances were washed
away and a substrate solution was added which turned the solution into a blue
color that was converted to yellow upon addition of a stop solution. The
absorbance was read at 450 nm using a plate reader. Minimum detectable
concentrations for TNF-a, IL-1 p, IL-6 and IL-10 were 5.1 pg/mL, 3.0 pg/mL, 1.6
pg/mL and 4.0 pg/mL respectively. The data were normalized to cell counts
obtained from processed spleen samples.

Oxidative burst and ROS Activity
The level of oxygen radical production by phagocytes was evaluated using
portions of spleen and liver as previously described (Wan, Myung, and Lau
1993). In this assay, DCFH-DA (Molecular Probes, Inc.), a membrane permeant
diacetate derivative of DCFH, was used as a probe. Both DCFH-DA and DCFH
are non-fluorescent fluorescein analogues that are oxidized to highly fluorescent
DCF by H2O2 and hydroperoxides. Zymosan A (Sigma) from yeast cell wall
(Saccharomyces cerevisiae) was used as a triggering agent. Background ROS
was quantified by not adding Zymosan to samples. Cells were plated into wells of
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96-microwell plates at a concentration of 2.5 x 106/well/0.1 ml and were
incubated for 1 hour at 37°C in 5% C02. DCFH-DA/Zymosan working solution
(150 mM DCFH-DA in 20 mg zymosan/ml Hanks Salt Solution) was then added
at 10 pl/well and the plates were re-incubated for 1 hour (37°C, 5% CO2). The
fluorescence intensity (RFU) was measured using a fluorometer at 490 nm
excitation and 530 nm emission.

cFos Immunohistochemistry
Brains were kept in vials containing 4% PFA and 2 g/ L of picric acid
solution overnight. As animals were not perfused at time of sacrifice, using picric
acid, allowed better fixation of the brain. The brains were then incubated in 30%
sucrose in PBS solution overnight. Brains were then washed 3x in PBS and
embedded in OCT embedding compound (Electron Microscopy Sciences
Hatfield, PA) and frozen. Using a cryostat, brains were sectioned into 30 micron
sections and placed in cryoprotectant solution consisting of 100 ml glycerol, 120
mL ethylene glycol and 180 mL 0.5 M phosphate buffer solution at pH 7.2.
Sections were washed 3x in PBS, 10 minutes per wash and were placed in 10%
normal goat serum (NGS) and incubated for 30 minutes. Sections were
transferred to sieves containing antibodies specific for cFos (rabbit) (1:5000
Abeam, Cambridge, MA) overnight at4°C. Sections were washed 3x with PBS
and placed in 10% NGS for 30 minutes followed by a 90 minute incubation in
secondary antibody (rabbit) (Abeam, Cambridge, MA). Sections were washed in
PBS for 10 minutes followed by a 25 minute incubation in a methanol bleach
solution containing 5 mL methanol, 8.32 mL 30% hydrogen peroxide and 85.2
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mL 0.15 M sodium phosphate buffer at pH 7.2. After 3 PBS washes, sections
were incubated in ABC (1:600 Vectasatain ABC kit, Vector Laboratories,
Burlingame, CA) solution for 90 minutes. After 2 PBS washes, sections were
incubated in 0.1 M acetate imidazole buffer at pH 7.4, followed by a 4-5 minute
incubation in 3,3'-Diaminobenzidine (DAB) (ACROS Organics, New Jersey)
solution containing 3 g nickel sulfate, 20 mg of DAB, 600 pL of 1% H2O2 and 120
mL of 0.1 M acetate imidazole buffer. Sections were washed in 1x acetate
imidazole buffer and 2x PBS and refrigerated overnight and were placed on glass
slide the following day. Samples were then dehydrated. Dehydration was
obtained by a 30s wash in H20, 1 minute wash in 70% ethanol, 2x 1 minute
washes in 95% ethanol, 1 minute wash in 100% ethanol followed by a 3 minute
wash in 100% ethanol. Slides were washed 2x in Histoclear (VWR,
Pennsylvania) followed by a 5-minute wash in histoclear. cFos stains were
quantified using Image-Pro software (Media Cybernetics, Bethesda, MD).

Catecholamine Quantification in Blood
After intra cardiac removal of blood, plasma was collected by centrifuging
blood samples at 200 g for 10 minutes. Fifty microliters of dihydroxybenzoic acid
(DHBA) was added per 200 pL of sample of plasma in addition to 1.0 mL of 0.1
M phosphate buffer at pH 7.0 and 1.0 mL of 1.5 M Iris buffer at pH 8.6. Fifty mg
of acid wash alumina (AAO) was added to each sample and samples were
incubated for 10 minutes on a shaker at room temperature. Samples were then
washed 3 times with 1.0 mL of dl H20 with a final addition of 400 pL of dl H20 to
each sample. The slurry was then be transferred to a microfilter tube, centrifuged
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at 1000 g for 2 minutes at room temperature and filtrate was collected. To each
sample, 200 pL of 0.1 M HCI04 was added and microfilter tubes were centrifuged
at 1000 g for 2 minutes at room temperature. Samples were then be analyzed
HPLC as described above and recovery was determined using DHBA as an
internal standard (Bellinger et al. 2005).

Catecholamine Quantification in Spleen
Ten pi of 1.0 M hypochloric acid (HCI04) was added per mg of spleen
sample. Samples were stored overnight at 4°C in order to obtaine better lysis of
cells and were homogenized the following day. Catecholamine concentration was
then determined by high pressure liquid chromatography (HPLC). Samples were
loaded into a Waters 717 plus autosampler (Waters, Milford, MA) and the mobile
phase was delivered at a constant flow rate of 1.0 ml/min by a Waters Model 510
pump through a C18, 5 pM, 250 mm x 4.6 mm analytical column (Alltech,
Deerfield, IL) placed in a column heater (35 °C). The LLC-4C amperometric
detector (Bioanalytical Systems, West Lafayette, IN) potential was set at 0.85 V
about an Ag-AgCI electrode and the sensitivity of the detector was maintained at
2 nA. The mobile phase was prepared by dissolving 0.1 M disodium phosphate,
0.1 M citrate, 0.1 mM EDTA, 1.4 mM octyl sodium sulfate, and 15% methanol in
1 L of nanopure water. The signal from the detector was recorded and the data
were analyzed using a Waters Millennium 2010 Chromatography Manager.
Samples corrected for recovery were compared with external standards to
determine NE concentration (Bellinger et al. 2005).
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Statistical Analysis
All data were evaluated with analysis of variance (ANOVA) by SPSS (SPSS.Inc.
Chicago, IL). Tukey’s test was performed for pair-wise multiple comparisons. P
values of <0.05 and between 0.05 and 0.1 were selected to indicate significance
and trend, respectively.

Results
Spleen Mass
An overall significant increase in spleen mass due to radiation (p<0.05)
was observed. However, post-hoc analysis indicated no significant differences
between in mass between individual groups (Fig. 21).

Splenocyte counts
There were significant radiation effects on the overall WBC (p<0.05) and
lymphocyte (p<0.001) counts (Fig. 22). There were also radiation-induced
changes in the proportions of all three major leukocyte populations (Fig. 23).
Lymphocyte proportions generally decreased (p<0.005), while monocyte and
granulocyte proportions increased (p<0.005 and p<0.001, respectively).
Radiation further enhanced the E. co//-induced increases in
monocyte/granulocyte proportions (p<0.05).
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Figure 21. Effects of radiation on spleen mass. Values represent
mean ± SEM (n=9/group). 8p<0.05 for main challenge effect.

108

36

E

34

2.8

E

32

1/5
<D

30

O
CO

28

X

26

o

3.0

Monocytes

WBC ^

1/5

2.6

CD

o
CO

2.4

o
X

2.2

24
22

2.0

12
24
£

Granulocytes

Lymphocytes $

11

22

2 20
o
co°
o
^

18

T-

14

X

E
1/5

10

0

o
9

CO

16
8

12

7
0 Gy

3 Gy

0 Gy

Radiation Dose

3 Gy

Radiation Dose

Figure 22. Effects of proton radiation on spleen total WBCs and leukocyte
subpopulations. Values represent mean ± SEM (n=9/group). *p<0.001 for
main radiation effect.

109

o
X

105

% Lymphocytes t

100
95
^

90
85
80
75

14.5

58
56
54
52
50
48
46
44
42
40
38

% Granulocytes t

% Monocytes t

14.0

13.5
13.0
12.5
12.0
11.5
0 Gy

3 Gy

0 Gy

Rad Dose

3 Gy

Rad Dose

Figure 23. Effects of proton radiation on proportions of spleen leukocyte
proportions. Values represent mean ± SEM (n=9/group). *p<0.001 for main
radiation effect.

110

^

Cytokines
Figure 24 shows the concentrations of the four measured cytokines. A
main effect of challenge was noted on all cytokines (ps<0.001). There were also
main effects of radiation on IL-1p (p<0.05) and IL-10 (p<0.001). Although post
hoc analysis indicated that radiation further enhanced the E. co//-induced
increase in IL-10 secretion (p<0.05), there were no significant radiation x
challenge interactions. There was a similar trend in IL-1p (p=0.055).
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Figure 24. Effects of proton radiation on spleen cytokine secretion. Values
represent mean ± SEM (n=9/group). tp<0.001 for main radiation effect,
p<0.05 for main challenge effect.
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Phagocytic Activity
There was a significant radiation effect on phagocytic activity in the spleen
(p<0.001), but none was obtained for challenge with E. coli (Fig. 25).

Oxidative Burst Activity
There was a significant radiation effect on background level of ROS
released by the spleen (p< 0.001). There was also a main radiation effect on
zymosan-induced increase these unstable oxygen species (Fig. 26).

Plasma Norepinephrine
There was a significant radiation effect on plasma NE levels (p<0.05)
where radiation caused an overall increase (Fig. 27). An effect due to challenge
with E. coli, however, did not occur.
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Spleen Norepinephrine
There was a trend for challenge (p=0.07), but no impact of radiation, on
spleen NE levels when reported in ng per spleen wet weight (Fig. 28). No
significant differences were noted in NE levels in whole spleen (Fig. 29).

cFos in PVN
There was a significant E. colix radiation interaction in cFos expression
(p<0.01) (Fig. 30). Post-hoc analyses indicated that exposure to E. co//alone led
to a significant increase in expression (p<0.05). Furthermore, there was a trend
for a radiation-dependent decrease in the E. co//response (p=0.076). Finally:
there were no significant effects of E. coli in the irradiated groups.
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Discussion
Although there were no observed radiation-induced changes in total
spleen mass based, overall splenic WBC counts were reduced in irradiated
animals. As there were no radiation-induced changes in splenic
monocyte/macrophage or granulocyte counts, this decrease was primarily due to
a decrease in lymphocyte counts. These results contrasts sharply with the
findings of the previous study where we found significant decreases in all major
splenic leukocyte subpopulations 8 days after exposure to whole-body irradiation.
As the major difference between the two studies was whole-body versus bodyonly radiation exposure, these changes suggest a link between the CNS and
leukocyte trafficking in the spleen and/or differences in reconstitution of the
various populations; however, the pathway and mechanism are currently
unknown.
Although the effect of radiation on leukocyte counts appears to be
dependent on whether or not the head was exposed, proportional shifts in these
populations were remarkably similar across studies. Specifically, lymphocyte
proportions were significantly reduced after radiation exposure, whereas the
percentages of monocytes and granulocytes increased, confirming the higher
radiosensitivity of lymphocytes compared to monocytes and granulocytes. Similar
results have been obtained using x-, y- and proton irradiation (Gridley, Andres,
and Slater 1997; Harrington et al. 1997; Hsu et al. 1996; Kajioka et al. 2000).
As noted previously, cytokines are crucial in communicating peripheral
inflammatory events to the rest of the immune system and to the CNS. Similar to
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our previous study, there were significant challenge-induced increases in the
inflammatory cytokines IL-1p, TNF-a and IL-6, as well as in the anti-inflammatory
cytokine, IL-10. However, because the mice in this study were assayed at 90
minutes (as opposed to 60 minutes in the previous study) there were some
variations in cytokine secretion patterns between experiments.
Body-only radiation exposure caused significant increases in IL-1p levels.
Radiation is known to have an inflammatory effect and, as we showed in our
previous experiment, can induce macrophages into a semi-active state.
Furthermore, as already shown, macrophages appear to be relatively
radioresistant in terms of counts and proportions. Combined, these results
suggest that a radiation-induced increase in IL-1p levels is expected. However,
we did not see this radiation effect at the appropriate time point in the previous,
whole-body study.
A dependence on the presence of an immune challenge may help explain
the apparent difference in the IL-ip results. Although there were no statistically
significant radiation x challenge interactions on this parameter, the radiationinduced increases generally occurred in the E. co//-treated groups. In the normal
response to an immunogenic challenge, TNF-a levels increase first, followed by
slightly delayed increases in IL-1p, IL-6 and, finally, IL-10 (See Fig. 31). One
possible explanation for the discrepancy may be that 60 minutes was too early in
the E. coli response for radiation to influence IL-1p. However, by increasing the
time between inoculation and sacrifice to 90 minutes, we were able to detect to a
radiation-sensitive shift in IL-1p secretion patterns. In other words, the effect of
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radiation on production of specific cytokines is dependent on the tinning of the
response. This may also explain the lack of a radiation effect on TNF-a and IL-6
in the present study compared to significant increases 60 minutes after wholebody irradiation.
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Increases in pro-inflammatory cytokines leads to the secretion of anti
inflammatory cytokines. Hence, the radiation-induced increase in IL-10 is
possibly due to the increases in IL-1p. Radiation-induced Increase in IL-10 from
T cells and B cells are unlikely as these cells are radiosensitive and the overall
lymphocyte counts are still low 8 days post-irradiation. However, macrophages
can also be induced to release IL-10. As with IL-1p, the increase in IL-10 may
reflect a proportional increase in macrophages.
The radiation-induced increase in oxidative burst activity is consistent with
our previous whole-body radiation study as well as those of other investigators
(Gallin and Green 1987; Ibuki and Goto 2000; Pandey et al. 2005). A significant
radiation-induced background oxidative burst activity was also observed,
suggesting that radiation may cause a long-term shift in favor of ROS production.
Radiation has been shown to increase activation of PKC, which plays an
important role in ROS release pathway (Ibuki and Goto 2000). This suggests that
the observed changes may be due to increased activation of signal transduction
molecules such as PKC, resulting in the eventual release of ROS. The increase
is also consistent with cytokine patterns indicating pro-inflammatory responses.
Evaluation of splenocytes showed a significant radiation-induced decrease
in ex vivo phagocytic activity. There are at least two other studies in the literature,
which report similar findings after exposure to x-rays (dwell et al. 2005;
Shechmeister and Fishman 1955). A reduction in phagocytic activity could
possibly be due to radiation-induced disruption of the cell cytoskeleton (Olwell et
al. 2005) essential for pathogen internalization. However, this result contrasts our
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previous results after whole-body exposure where we found significant increases
in phagocytic activity in both the spleen and the liver. Furthermore, several
additional studies have reported that exposure to y- and x-rays (Conrad, Ritter,
and Nixdorff; Lorimore et al. 2001) lead to increased phagocytic activity. As the
spleen was exposed to the same dose of radiation in both studies, direct
disruptions in cellular structure may not be the sole factor involved in radiationinduced functional changes.
As mentioned above, the changes in cytokines evaluated suggest that
radiation-exposed mice are in a transitional state from a pro-inflammatory
response to one that is anti-inflammatory. Hence, the decrease in phagocytic
activity observed is possibly due to radiation-induced shifts in cytokine secretion
patterns. As the only difference between the two studies is exposure to the brain
the observed differences must be attributed to radiation-induced changes in the
CNS. This strongly suggests that radiation can impact the link between the CNS
and the spleen at a functional level. However, specific mechanisms have yet to
be elucidated.
Body-only exposure diminished the E. co//-induced increase in PVN cFos
activity. The HPA axis has an important role in the response to a bacterial
infection and its activity is regulated primarily by CRH producing neurons in the
PVN, which receives innervation from the NTS. Studies have shown that the NTS
is a major recipient of peripheral immune signals conveyed via vagal afferent
fibers (Adachi 1984). Sensory vagal afferent fibers are able to detect low levels of
cytokine and other inflammatory mediators in peripheral tissues, and lymphoid
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organs such as spleen and liver (Johnston and Webster 2009). Activation of this
pathway is marked by an increase in cFos-like immunoreactivity in several CNS
tissues, including the PVN. There have been conflicting reports on the effect of
radiation on HPA axis activation. Studies have shown increases in HPA axis
activation with y-radiation (Lebaron-Jacobs, Wysocki, and Griffiths 2004) and
decreases with x-rays (Liu 2004). However, no immune challenge was given to
the animals (rats and mice) used in either of these previous studies.
As reported earlier, ionizing radiation can lead to release of free radicals.
These radicals can cause oxidative damage of nucleic acids, lipids,
carbohydrates and proteins. Hence, the diminished cFos immunoreactivity
observed in this investigation is possibly due to radiation-induced damage to the
vagal afferent fibers and cytokine receptors on vagal fibers leading to the
disruption of signaling from spleen to the NTS and hence a decrease in cFos
counts in the PVN. However, this explanation cannot account for the lack of
detectable, radiation-dependent changes in PVN cFos activity after whole-body
exposure. Another possibility is that exposing the brain to radiation simply
dampened the response to E. coli. However, as observed in both studies,
radiation alone did not appear to have any effect on cFos activity in the PVN
regardless of exposure to the brain. Therefore, the differences noted between the
two studies are likely due to differences in timing of cFos expression post
challenge, resulting in the lack of cFos activity at 60 minutes and detectable
changes 90 minutes post-inoculation.
As with the HPA axis, increases in inflammatory cytokines lead to the
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activation of the SNS pathway. This activation results in the release of NE from
adrenergic nerves in the spleen, which then modulate the inflammatory response
in presence of an immune challenge via adrenergic receptors on leukocytes. As
radiation causes an overall increase in inflammatory responses as seen with
increases in IL-1p, a greater NE release would be expected upon SNS activation.
However, there were no significant radiation-induced or challenge-induced
changes in the amount of NE released into the spleen. This is somewhat
surprising given the changes noted in PVN cFos levels. Again, this may be a
matter of timing (i.e. 90 minutes is not long enough to result in measurable
changes in splenic NE levels).
Surprisingly, despite the lack of a radiation-response in splenic NE levels,
there was an overall radiation-induced increase in plasma levels of this
catecholamine. Many studies have used plasma NE levels to reflect changes in
SNS and based on the result obtained from this study, this may not be a true
representation of SNS signaling. The liver, kidneys, heart, muscles and adrenals
release NE and studies have shown that there is spillover of NE from these
organs into the blood (Goldstein et al. 1983; Kopin et al. 1998; Leinhardt et al.
1993). Hence, the increase in plasma NE may reflect an increase in NE from
other organs. However, because we only characterized the spleen, the source is
currently unknown.
In summary, the data presented here indicate that radiation can have an
impact on immune-CNS communication. Experiment-dependent differences were
noted in splenic leukocyte population distributions, pro- and anti-inflammatory
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cytokine levels, phagocytosis, and cFos expression. Although some of the
contrasts are likely due to differences in the interval between E. co//challenge
and time of assessment, many of the changes appear do implicate radiationinduced changes in the CNS. However, further study is necessary to specifically
identify and describe the mechanisms involved.
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CHAPTER FIVE
SUMMARY OF FINDINGS AND CONCLUSIONS

With the increased international emphasis on interplanetary exploration
future astronauts will take part in increasingly extended voyages, exposing them
to several risks of spaceflight environment. Two of the more important risk factors
are changes in inertial conditions and long-term exposure to radiation. Studies in
both animals and humans have shown that these two factors result in many
phyiological changes, including those which could influence both the immune and
the central nervous systems. Given the clear link between the immune and CNS
in maintaining immune homeostasis, a disruption in the communication pathway
between these two systems could pose a serious threat to astronaut health. To
address this concern, we conducted a series of experiments in which mice were
exposed to gravitational changes that occur during a space flight mission, or to
proton radiation at doses comparable to a large SPE. The overall hypothesis of
this study was: Exposure to spaceflight environment (microgravity and radiation)
influence immune responses by upregulation of the innate immune response,
altering cytokine expression and ultimately influencing CNS-immune
communication.
Data from both the spaceflight and whole-body proton irradiation studies
show significant reductions in spleen mass. This is consistent with previous
spaceflight and proton radiation studies (Durnova, Kaplansky, and Portugalov
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1976; Gridley et al. 2003; Kajioka et al. 2000; Pecaut, Nelson, and Gridley 2001;
Pecaut et al. 2003). These changes in spleen mass are possibly due to lymphoid
tissue atrophy caused by the release of glucocorticoids and catecholamines as a
result of spaceflight stress, and ionizing radiation-induced damage as a result of
proton radiation exposure. The spleen is the largest secondary lymphoid organ
and is essential for removal of pathogens, as well as inanimate materials that
may be harmful. Thus, atrophy of the spleen in both cases can lead to serious
immune impairment. There were no radiation-induced changes in spleen mass in
the body-only radiation study, suggesting that the brain possibly has a role in
decreasing radiation-induced atrophy in spleen.
Although radiation and spaceflight appear to have a similar effect on all
major leukocyte population counts, proportional shifts in the various cell types
were risk factor-dependent. Specifically, spaceflight had no significant effect on
leukocyte distributions, whereas, radiation led to a shift away from lymphocytes
toward monocytes and granulocytes. These differences suggest that leukocytes
vary in their resistance to the different environmental stressors
The potential for shifts in population distribution is further complicated by
differences in the response to whole-body radiation versus body-only radiation.
The decreases in monocyte and granulocyte percentages occurred only after
whole-body irradiation, but not body-only exposure, thereby suggesting that
radiation impacts communication and the kinetics between the CNS and the
spleen. Because the radiation-induced decreases in cell counts were far greater
than those due to spaceflight, we believe that the radiation response will
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dominate proportional shifts should astronauts be exposed to both risk factors
simultaneously. However, as both aspects of the spaceflight environment may
impact HPA/SNS activity, there is the potential for additive or even synergistic
interactions between these environmental factors.
Alterations in cytokine secretion patterns due to spaceflight and exposure
to ionizing radiation have been reported (Chapes et al. 1992; Gridley et al. 2003;
Linard et al. 2004). In our spaceflight study, we found a decrease in TNF-oc, a
potent pro-inflammatory cytokine, and increases in anti-inflammatory cytokines
IL-6 and IL-10. The response to radiation appears to be transient, with an early
increase in TNF-a, followed by delayed increases in IL-1p and IL-10. To the best
of our knowledge, this is the first time splenic cytokine expression has been
evaluated after a live in vivo challenge in a proton-irradiated animal model. It is
important to note that the cytokines were elicited ex vivo in the spaceflight
studies, while the response was initiated in vivo in the radiation studies.
Therefore, several variable factors are introduced, including time of incubation
with immune challenge, circulation of leukocytes in response to immune
challenge and population of leukocyte responding to the challenge. Despite these
differences in technique, a comparison of results could be constructive.
The changes in cytokine secretion after spaceflight were possibly due to
changes in in vivo glucocorticoid and catecholamine levels as a result of
psychological and physiological stress inherent to the spaceflight environment as
well as stress of landing. Although we did not measure these endpoints in the
present study, previous studies have shown spaceflight-induced increases in
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circulating glucocorticoid and catecholamine levels (Fleming, Edelman, and
Chapes 1991; Grindeland et al. 1990), suggesting an increase in HPA/SNS
activity. The exposure of splenocytes to these endocrine molecules prior to tissue
extraction, followed by treatment with LPS in vitro may have lead to an overall
decrease in pro-inflammatory response and a shift towards a state indicative of a
Th2 response. In contrast, the response to radiation appears to be proinflammatory. Clearly, these results suggest that both risk factors will have an
impact on cytokine secretion. Unfortunately, because of variations in the time of
interval between E. co//challenge and assessment of cFos expression in our
radiation studies, we cannot directly implicate HPA/SNS activity in changes in
cytokine expression. However, the radiation and inertial/stress responses appear
to be opposed to one another and we cannot determine which will dominate the
overall response to the spaceflight environment without further study.
Studies have shown changes in production of ROS in both spaceflight and
ionizing radiation studies. All three experiments conducted in this study indicate
that spaceflight and radiation lead to an increase in ROS production. In the
spaceflight study, significant increases in many genes responsible for scavenging
ROS were found. These changes can be attributed to regaining homeostasis
upon landing, suggesting an increase in the amount of ROS during spaceflight.
Similarly, our whole-body and body-only radiation exposure studies both indicate
a radiation-induced increase in both background and immune challenge-induced
oxidative burst activity and hence an overall increase in ROS levels.
As many of the effects of spaceflight are similar to those of radiation, we
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suspect that functional changes may also be similar. In the spaceflight study,
decrease in proliferative response to IPS was noted, indicating a compromised
response to a B cell mitogen. This suggests that response to Gram-negative
bacteria may be down-regulated, since LPS is a component of these organisms.
A whole-body radiation-induced increase in phagocytic activity and increase in
efficiency to clear bacteria in the blood were noted. In addition, there were
significant increases in the expression of MHC II molecules as a result of wholebody radiation exposure. These results indicate similar responses in terms of
upregulation of innate immune response; the increased MHC II expression also
suggests enhanced potential for antigen presentation to Th cells and subsequent
activation of adaptive immunity. Furthermore, differences in phagocytic activity
were noted between the two radiation studies, implicating HPA/SNS involvement
in the radiation response.
Although we were unable to measure glucocorticoid and catecholamine
levels in the spaceflight study (due to the need for blood and tissue sharing
among many investigators), the decreases in lymphoid organ masses, increase
in ROS levels and change in cytokine secretion patterns indicate that the mice
experienced physiological and/or psychological stress. Hence we postulate that
there was an increase in these endocrine molecules and a possible over
activation of HPA/SNS pathways. Even though we were unable to detect any
radiation-induced changes in splenic NE levels, we did find radiation-induced
increases in plasma NE, as well as radiation-induced decrements in E. coliinduced in cFos expression in the PVN in the body-only irradiated mice. Although
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the tinning and the mechanisms of these responses are still in question, it seems
clear that both spaceflight and radiation can impact HPA/SNS activity.
Our data indicate that spaceflight-related stressors may pose serious
health risks to astronauts. The depression in lymphoid organs and leukocyte
populations can lead to an impaired immune response to infectious pathogens. In
addition, both spaceflight and radiation exposure result in changes in cytokine
patterns. This not only disrupts the appropriate response to a pathogen, but can
also put astronauts at risk for mental disorders such as depression. Studies have
shown a link between changes in circulating cytokine levels and mood disorders
(Anisman et al. 2005). Impaired signaling from peripheral immune system to the
CNS, increases in innate immune responses and increases in release of ROS
may also compromise an adaptive immune response to infections. These
increases in inflammatory responses, if chronic, can lead to tissue atrophy, which
can potentially further up-regulate inflammatory responses and possibly lead to
chronic inflammatory diseases. To ensure astronaut safety and survival during
long duration missions, it is essential to elucidate the pathways involved in these
immune changes.

135

REFERENCES
Adachi, A. 1984. Projection of the hepatic vagal nerve in the medulla oblongata.
J Auton Nerv SysMO, no. 3-4: 287-93.
Ader, Robert, David L. Felten, and Nicholas Cohen. 2001.
Psychoneuroimmunology. San Diego: Academic Press.
Aderem, A. 2003. Phagocytosis and the inflammatory response. J Infect Dis 187
Suppl 2: S340-5.
Allan, S. M. 2000. The role of pro- and antiinflammatory cytokines in
neurodegeneration. Ann N Y Acad Sc/917: 84-93.
Allebban, Z., A. T. Ichiki, L. A. Gibson, J. B. Jones, C. C. Congdon, and R. D.
Lange. 1994. Effects of spaceflight on the number of rat peripheral blood
leukocytes and lymphocyte subsets. J Leukoc Biol 55, no. 2: 209-13.
Anisman, H., Z. Merali, M. O. Poulter, and S. Hayley. 2005. Cytokines as a
precipitant of depressive illness: Animal and human studies. Curr Pharm
Des 11, no. 8: 963-72.
Bach, MA. 1975. Differences in cyclic AMP changes fter stimulation by
prostaglandins and isoproterenol in lymphocyte subpopulations. J Clin
Invest 55: 4.
Banks, W. A., L. Ortiz, S. R. Plotkin, and A. J. Kastin. 1991. Human interleukin
(IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from
blood to brain in the mouse by a shared saturable mechanism. J
Pharmacol Exp Ther 259, no. 3: 988-96.
Batistaki, C., G. Kostopanagiotou, P. Myrianthefs, C. Dimas, P. Matsota, A.
Pandazi, and G. Baltopoulos. 2008. Effect of exogenous catecholamines
on tumor necrosis factor alpha, interleukin-6, interleukin-10 and betaendorphin levels following severe trauma. Vascul Pharmacol 48, no. 2-3:
85-91.
Bellinger, D. L., S. Y. Felten, D. Lorton, and D. L. Felten. 1989. Origin of
noradrenergic innervation of the spleen in rats. Brain Behav Immun 3, no.
4: 291-311.
Bellinger, D. L., D. Lorton, T. D. Romano, J. A. Olschowka, S. Y. Felten, and D.
L. Felten. 1990. Neuropeptide innervation of lymphoid organs. Ann N Y
Acad Sci 594: 17-33.
136

Bellinger, D. L, S. Y. Stevens, S. Thyaga Rajan, D. Lorton, and K. S. Madden.
2005. Aging and sympathetic modulation of immune function in fischer
344 rats: Effects of chemical sympathectomy on primary antibody
response. J Neuroimmunon65, no. 1-2: 21-32.
Berkowitz, D. E. 2007. Microgravity and cardiac atrophy: No sex descrimination.
J Appl Physiol 103: 2.
Besedovsky, H. O. and A. del Rey. 1996. Immune-neuro-endocrine interactions:
Facts and hypotheses. EndocrRevAl, no. 1: 64-102.
Bishopric, N. H., H. J. Cohen, and R. J. Lefkowitz. 1980. Beta adrenergic
receptors in lymphocyte subpopulations. J Allergy Clin Immunol 65, no. 1:
29-33.
Bogdan, C., M. Rollinghoff, and A. Diefenbach. 2000. Reactive oxygen and
reactive nitrogen intermediates in innate and specific immunity. Curr Opin
Immunol 12, no. 1: 64-76.
Bogdan, C., M. Rollinghoff, and A. Diefenbach. 2000. The role of nitric oxide in
innate immunity. Immunol Rev '\73: 17-26.
Botchkina, G. I., M. E. Meistrell, 3rd, I. L. Botchkina, and K. J. Tracey. 1997.
Expression of TNF and TNF receptors (p55 and p75) in the rat brain after
focal cerebral ischemia. Mol Med 3, no. 11: 765-81.
Brady, L. S., A. B. Lynn, M. Herkenham, and Z. Gottesfeld. 1994. Systemic
interleukin-1 induces early and late patterns of c-Fos mRNS expression in
brain. J Neurosci 14, no. 8: 4951-64.
Brissette, W. H., D. A. Baker, E. J. Stam, J. P. Umland, and R. J. Griffiths. 1995.
Gm-csf rapidly primes mice for enhanced cytokine production in response
to LPS and TNF. Cytokine 7, no. 3: 291-5.
Bryant, P. and H. Ploegh. 2004. Class II MHC peptide loading by the
professionals. Curr Opin Immunol “Id, no. 1: 96-102.
Carrero, J. J., M. Chmielewski, J. Axelsson, S. Snaedal, O. Heimburger, P.
Barany, M. E. Suliman, B. Lindholm, P. Stenvinkel, and A. R. Qureshi.
2008. Muscle atrophy, inflammation and clinical outcome in incident and
prevalent dialysis patients. Clin Nutr27, no. 4: 557-64.
Casals, C., M. Barrachina, M. Serra, J. Lloberas, and A. Celada. 2007.
Lipopolysaccharide up-regulates mhc class ii expression on dendritic cells
through an AP-1 enhancer without affecting the levels of ciita. J Immunol
178, no. 10: 6307-15.

137

Cesta, M. F. 2006. Normal structure, function, and histology of the spleen.
Toxicol Pathol 34, no. 5: 455-65.
Chapes, S. K., D. R. Morrison, J. A. Guikema, M. L. Lewis, and B. S. Spooner.
1992. Cytokine secretion by immune cells in space. J Leukoc Biol 52, no.
1:104-10.
Chapes, S. K., S. J. Simske, G. Sonnenfeld, E. S. Miller, and R. J. Zimmerman.
1999. Effects of spaceflight and PEG-IL-2 on rat physiological and
immunological responses. J Appl Physiol 86, no. 6: 2065-76.
Cheers, C. and R. Waller. 1975. Activated macrophages in congenittally athymic
"Nude mice" And in lethally irradiated mice. J Immunol 115, no. 3: 3.
Chiriva-lnternati, M., F. Grizzi, J. Pinkston, K. J. Morrow, N. D'Cunha, E. E.
Frezza, P. C. Muzzio, W. M. Kast, and E. Cobos. 2006. Gamma-radiation
upregulates MHC class I/ll and ICAM-I molecules in multiple myeloma cell
lines and primary tumors. In Vitro Cell Dev Biol Anim 42, no. 3-4: 89-95.
Chong, Y. H., S. A. Shin, H. J. Lee, J. H. Kang, and Y. H. Suh. 2002. Molecular
mechanisms underlying cyclic AMP inhibition of macrophage dependent
TNF-alpha production and neurotoxicity in response to amyloidogenic Cterminal fragment of alzheimer's amyloid precursor protein. J
Neuroimmunon33, no. 1-2: 160-74.
Chow, J. C., D. W. Young, D. T. Golenbock, W. J. Christ, and F. Gusovsky.
1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal
transduction. J Biol Chem 274, no. 16: 10689-92.
Cogoli, A. 1997. Signal transduction in t lymphocytes in microgravity. Gravit
Space Biol Bull 10, no. 2: 5-16.
Conde, G. L., D. Renshaw, B. Zubelewicz, S. L. Lightman, and M. S. Harbuz.
1999. Central LPS-induced c-fos expression in the PVN and the A1/A2
brainstem noradrenergic cell groups is altered by adrenalectomy.
Neuroendocrinology 70, no. 3: 175-85.
Congdon, C. C., Z. Allebban, L. A. Gibson, A. Kaplansky, K. M. Strickland, T. L.
Jago, D. L. Johnson, R. D. Lange, and A. T. Ichiki. 1996. Lymphatic tissue
changes in rats flown on spacelab life sciences-2. J Appl Physiol 8^1, no. 1:
172-7.
Conrad, s, S Ritter, and K Nixdorff. Phagocytic activity of macrophages after
exposure to ionising radiation. Radiation-Biophysics 22.
Correa, S. G., M. Maccioni, V. E. Rivero, P. Iribarren, C. E. Sotomayor, and C. M.
Riera. 2007. Cytokines and the immune-neuroendocrine network: What

138

did we learn from infection and autoimmunity? Cytokine Growth Factor
RevJ\Q, no. 1-2: 125-34.
Crucian, B. E., M. L. Cubbage, and C. F. Sams. 2000. Altered cytokine
production by specific human peripheral blood cell subsets immediately
following space flight. J Interferon Cytokine Res 20, no. 6: 547-56.
Dantzer, R. 2005. Somatization: A psychoneuroimmune perspective.
Psychoneuroendocrinology 30, no. 10: 947-52.
Dantzer, R., R. M. Bluthe, S. Laye, J. L. Bret-Dibat, P. Parnet, and K. W. Kelley.
1998. Cytokines and sickness behavior. Ann N Y Acad Sci 840: 586-90.
DeRijk, R, D Michelson, B Karp, J Petrides, E Galliven, P Deuster, G Paciotti,
P.W Gold, and E.M Sternberg. 1997. Exercise and circadian rhythminduced variations in plasma cortisol differentially regulate interleukin1beta (il-1b, il-6, and tumor necrosis factor alpha (TNF-a) production in
humans: High sensitivity of tnf-alpha and resistance of IL-6. J Clin End
Met 82, no. 7: 10.
Dhabhar, F. S. and B. S. McEwen. 1999. Enhancing versus suppressive effects
of stress hormones on skin immune function. Proc Natl Acad Sci USA
96, no. 3: 1059-64.
Durnova, G. N., A. S. Kaplansky, and V. V. Portugalov. 1976. Effect of a 22-day
space flight on the lymphoid organs of rats. Aviat Space Environ MedAJ,
no. 6: 588-91.
Elenkov, I. J. 2008. Neurohormonal-cytokine interactions: Implications for
inflammation, common human diseases and well-being. Neurochem Int
52, no. 1-2: 40-51.
Ericsson, A., K. J. Kovacs, and P. E. Sawchenko. 1994. Afunctional anatomical
analysis of central pathways subserving the effects of interleukin-1 on
stress-related neuroendocrine neurons. J Neurosci *14, no. 2: 897-913.
Eskandari, F. and E. M. Sternberg. 2002. Neural-immune interactions in health
and disease. Ann N Y Acad Sci 966: 20-7.
Eskandari, F., J. I. Webster, and E. M. Sternberg. 2003. Neural immune
pathways and their connection to inflammatory diseases. Arthritis Res
TherS, no. 6: 251-65.
Febbraio, M. A. and B. K. Pedersen. 2005. Contraction-induced myokine
production and release: Is skeletal muscle an endocrine organ? Exerc
Sport Sci Rev 33, no. 3: 114-9.

139

Felten, S. Y., D. L. Felten, D. L. Bellinger, S. L. Carlson, K. D. Ackerman, K. S.
Madden, J. A. Olschowka, and S. Livnat. 1988. Noradrenergic
sympathetic innervation of lymphoid organs. Prog Allergy 43: 14-36.
Felten, S. Y. and J. Olschowka. 1987. Noradrenergic sympathetic innervation of
the spleen: li. Tyrosine hydroxylase (TH)-positive nerve terminals form
synapticlike contacts on lymphocytes in the splenic white pulp. J Neurosci
Res 18, no. 1: 37-48.
Fleming, S.D, L.S Edelman, and S. K. Chapes. 1991. Effects of corticosterone
and microgravity on inflammatory cell production of superoxide. J Leukoc
Biol 50, no. 1: 8.
Fleshner, M., L. E. Goehler, J. Hermann, J. K. Relton, S. F. Maier, and L. R.
Watkins. 1995. Interleukin-1 beta induced corticosterone elevation and
hypothalamic ne depletion is vagally mediated. Brain Res Bull 37, no. 6:
605-10.
Forman, H. J. and M. Torres. 2001. Signaling by the respiratory burst in
macrophages. lUBMB Life 51, no. 6: 365-71.
Fu, Z. F., E. Weihe, Y. M. Zheng, M. K. Schafer, H. Sheng, S. Corisdeo, F. J.
Rauscher, 3rd, H. Koprowski, and B. Dietzschold. 1993. Differential effects
of rabies and borna disease viruses on immediate-early- and lateresponse gene expression in brain tissues. J Virol 67, no. 11: 6674-81.
Gallin, E.K and S.W Green. 1987. Exposure to gamma-irraditaion increases
phorbol myristate acetate-induced H2O2 production in human
macrophages, blood 70: 7.
Gao, B., W. I. Jeong, and Z. Tian. 2008. Liver: An organ with predominant innate
immunity. Hepatology 47, no. 2: 729-36.
Gaykema, R. P., I. Dijkstra, and F. J. Tilders. 1995. Subdiaphragmatic vagotomy
suppresses endotoxin-induced activation of hypothalamic corticotropin
releasing hormone neurons and acth secretion. Endocrinology 'lOO, no.
10:4717-20.
Georgieva, N.V. 2005. Oxidative stress as a factor of disrupted ecological
oxidative balance in biological systems- a review. Bulgarian J Vet Med. 8:
10.
Goldsby, RA, Thomas J. Kindt, BA Osborne, and J Kuby. 2003. Immunolgy. New
York: W.H Freeman And Company.
Goldsby, RA, TJ Kindt, BA Osborne, and J Kuby. 2003. Immunlogy. Immunology.
New York: W.H Freeman and Company.

140

Goldstein, D.S, R McCarty, R.J Polinsky, and I.J Kopin. 1983. Relationship
between plasma norepinephrine and sympathetic neural activity.
Hypertension 5: 7.
Gould, C. L, M. Lyte, J. Williams, A. D. Mandel, and G. Sonnenfeld. 1987.
Inhibited interferon-gamma but normal interleukin-3 production from rats
flown on the space shuttle. Aviat Space Environ Med 58, no. 10: 983-6.
Gridley, D. S., M. L. Andres, and J. M. Slater. 1997. Enhancement of prostate
cancer xenograft growth with whole-body radiation and vascular
endothelial growth factor. Anticancer Res 17, no. 2A: 923-8.
Gridley, D. S., D. G. Mackensen, J. B. Slater, M. F. Moyers, and J. M. Slater.
1995. Effects of proton irradiation on radiolabeled monoclonal antibody
uptake in human colon tumor xenografts. J Immunother Emphasis Tumor
Immunol “W, no. 4: 229-37.
Gridley, D. S., G. A. Nelson, L. L. Peters, P. J. Kostenuik, T. A. Bateman, S.
Morony, L. S. Stodieck, D. L. Lacey, S. J. Simske, and M. J. Pecaut. 2003.
Genetic models in applied physiology: Selected contribution: Effects of
spaceflight on immunity in the C57BL/6 mouse. II. Activation, cytokines,
erythrocytes, and platelets. J Appl Physiol 94, no. 5: 2095-103.
Gridley, D. S., M. J. Pecaut, R. Dutta-Roy, and G. A. Nelson. 2002. Dose and
dose rate effects of whole-body proton irradiation on leukocyte populations
and lymphoid organs: Part I. Immunol Lett 80, no. 1: 55-66.
Gridley, D. S., M. J. Pecaut, G. M. Miller, M. F. Moyers, and G. A. Nelson. 2001.
Dose and dose rate effects of whole-body gamma-irradiation: II:
Hematological variables and cytokines. In Vivo 15, no. 3: 209-16.
Gridley, D. S., M. J. Pecaut, and G. A. Nelson. 2002. Total-body irradiation with
high-LET particles: Acute and chronic effects on the immune system. Am
J Physiol Regul Integr Comp Physiol 282, no. 3: R677-88.
Grindeland, R. E., I. A. Popova, M. Vasques, and S. B. Arnaud. 1990. Cosmos
1887 mission overview: Effects of microgravity on rat body and adrenal
weights and plasma constituents. FASEB J4, no. 1: 105-9.
Grinevich, V., X. M. Ma, J. Verbalis, and G. Aguilera. 2001. Hypothalamic
pituitary adrenal axis and hypothalamic-neurohypophyseal
responsiveness in water-deprived rats. Exp A/euro/171, no. 2: 329-41.
Grove, D. S., S. A. Pishak, and A. M. Mastro. 1995. The effect of a 10-day space
flight on the function, phenotype, and adhesion molecule expression of
splenocytes and lymph node lymphocytes. Exp Cell Res 2^9, no. 1: 102-9.

141

Guillot, C, J.G Steinberg, S Delliaux, N Kipson, Y Jammes, and M Badier. 2008.
Physiological, histological and biochemical properties of rat skeletal
muscles in response to hindlimb suspension. J Electromyogr Kinesiol J\Q,
no. 2: 7.
Harrington, N. P., K. A. Chambers, W. M. Ross, and L. G. Filion. 1997. Radiation
damage and immune suppression in splenic mononuclear cell
populations. Clin Exp Immunol '\07, no. 2: 417-24.
Hasko, G., I. J. Elenkov, V. Kvetan, and E. S. Vizi. 1995. Differential effect of
selective block of alpha 2-adrenoreceptors on plasma levels of tumour
necrosis factor-alpha, interleukin-6 and corticosterone induced by bacterial
lipopolysaccharide in mice. J Endocrinol 144, no. 3: 457-62.
Hawkly, L.C, J.A Bosch, C.G Engeland, P.T Marucha, and J.T Cacioppo. 2007.
Loneliness, dysphoria, stress, and immunity: A role for cytokines. In
Cytokines: Stress and immunity, ed. N.P Plotnikoff, R.E Faith, A.J Murgo
and R.A Good:405: CRC.
Heijnen, C. J. 2007. Receptor regulation in neuroendocrine-immune
communication: Current knowledge and future perspectives. Brain Behav
Immun 21, no. 1: 1-8.
Hellweg, C. E. and C. Baumstark-Khan. 2007. Getting ready for the manned
mission to mars: The astronauts' risk from space radiation.
Naturwissenschaften 94, no. 7: 517-26.
Hoffman, S.J. and D.l. Kaplan. 1997. Human exploration of mars: The reference
mission of the nasa mars exploration study team. . Houston: NASA.
Holloway, A. F., S. Rao, and M. F. Shannon. 2002. Regulation of cytokine gene
transcription in the immune system. Mol Immunol 3Q, no. 8: 567-80.
Hopkins, S. J. 2007. Central nervous system recognition of peripheral
inflammation: A neural, hormonal collaboration. Acta Biomed 7Q Suppl 1:
231-47.
Hosoi, Y, H Miyachi, Y Matsumoto, A Enomoto, K Nakagawa, N Suzuki, and T
Ono. 2001. Induction of interleukin-1 beta and interleukin-6 mRNA by low
doses of ionizing radation in macropages. IntJ. Cancer (Radiat. Oncol.
Invest) 96: 6.
Hsu, H. Y., J. J. Yang, S. L. Lian, Y. H. Ho, and C. C. Lin. 1996. Recovery of the
hematopoietic system by si-jun-zi-tang in whole body irradiated mice. J
Ethnopharmacol 54, no. 2-3: 69-75.
Hughes, D. A., I. P. Fraser, and S. Gordon. 1995. Murine macrophage scavenger
receptor: In vivo expression and function as receptor for macrophage

142

adhesion in lymphoid and non-lymphoid organs. Eur J Immunol 25, no. 2:
466-73.
Hughes-Fulford, M. 1991. Altered cell function in microgravity. Experimental
Gerontology 26: 9.
Ibuki, Y and R Goto. 2000. Enhancement of O2" production from resident
peritoneal macrophages by low-dose in vivo gamma irradiation. Biol.
Pharm. Bull 23, no. 9: 2.
Iosif, R. E., C. T. Ekdahl, H. Ahlenius, C. J. Pronk, S. Bonde, Z. Kokaia, S. E.
Jacobsen, and O. Lindvall. 2006. Tumor necrosis factor receptor 1 is a
negative regulator of progenitor proliferation in adult hippocampal
neurogenesis. J Neurosci 26, no. 38: 9703-12.
Jahns, G., Meylor J., Fast, T., Hawes, N., Zarow G. 1992. Rodent growth,
behavior, and physiology resulting from flight on the Space Life Sciences1 mission. International Astronatical Congress, 43rd, Washington, DC: 7.
Johnston, G. R. and N. R. Webster. 2009. Cytokines and the immunomodulatory
function of the vagus nerve. Br J Anaesth 102, no. 4: 453-62.
Jones, S. A. 2005. Directing transition from innate to acquired immunity: Defining
a role for il-6. J Immunol '\75, no. 6: 3463-8.
Kajioka, E. H., M. L. Andres, J. Li, X. W. Mao, M. F. Moyers, G. A. Nelson, J. M.
Slater, and D. S. Gridley. 2000. Acute effects of whole-body proton
irradiation on the immune system of the mouse. Radiat Res 153, no. 5 Pt
1: 587-94.
Kaur, I., E. R. Simons, V. A. Castro, C. Mark Ott, and D. L. Pierson. 2004.
Changes in neutrophil functions in astronauts. Brain Behav Immun 18, no.
5: 443-50.
Kaur, I., E. R. Simons, V. A. Castro, C. M. Ott, and D. L. Pierson. 2005. Changes
in monocyte functions of astronauts. Brain Behav Immun 19, no. 6: 54754.
Kidd, P. 2003. Th1/th2 balance: The hypothesis, its limitations, and implications
for health and disease. Altern Med Rev 8, no. 3: 223-46.
Kielian, T. and W. F. Hickey. 2000. Proinflammatory cytokine, chemokine, and
cellular adhesion molecule expression during the acute phase of
experimental brain abscess development. Am J Pathol 57, no. 2: 647-58.
Kitamura, H., Shiva, D., Woods, J.A., Yano, H. 2007. Beta-adrenergic receptor
blockade attenuates the exercise induced suppression of TNF-alpha in
response to lipopolysaccharide in rats. Neuroimmunomodul. 14, no. 2: 5.

143

Klaus, D. M. and H. N. Howard. 2006. Antibiotic efficacy and microbial virulence
during space flight. Trends Biotechnol24, no. 3: 131-6.
Kohm, A. P., Y. Tang, V. M. Sanders, and S. B. Jones. 2000. Activation of
antigen-specific CD4+ Th2 cells and B cells in vivo increases
norepinephrine release in the spleen and bone marrow. J /mmi/no/165,
no. 2: 725-33.
Kopin, I. J., B. Rundqvist, P. Friberg, J. Lenders, D. S. Goldstein, and G.
Eisenhofer. 1998. Different relationships of spillover to release of
norepinephrine in human heart, kidneys, and forearm. Am J Physiol 275,
no. 1 Pt 2: R165-73.
Kubera, M., Maes M., Holan, V., Basta-Kaim, A., Roman A., Shani, J. 2001.
Prolonged desipramine treatment increases production of interleukin-10
and anti-inflammatory cytokine, in C57BL/6 mice subjected to chronic mild
stress model of depression. J Affective Disorders 61: 7.
Kudoh, G., K. Hoshi, and T. Murakami. 1979. Fluorescence microscopic and
enzyme histochemical studies of the innervation of the human spleen.
Arch Histol Jpn 42, no. 2: 169-80.
Lambert, L. E. and D. M. Paulnock. 1987. Modulation of macrophage function by
gamma-irradiation. Acquisition of the primed cell intermediate stage of the
macrophage tumoricidal activation pathway. J /mmtvno/139, no. 8: 283441.
Lambeth, J. D. 2004. Nox enzymes and the biology of reactive oxygen. Nat Rev
Immunol 4, no. 3: 181-9.
Landmann, R. M., E. Burgisser, M. Wesp, and F. R. Buhler. 1984. Betaadrenergic receptors are different in subpopulations of human circulating
lymphocytes. J Recept Res 4, no. 1-6: 37-50.
Lebaron-Jacobs, L., J. Wysocki, and N. M. Griffiths. 2004. Differential qualitative
and temporal changes in the response of the hypothalamus-pituitaryadrenal axis in rats after localized or total-body irradiation. Radiat Res
161, no. 6: 712-22.
Leendertse, M., R. J. Willems, I. A. Giebelen, P. S. van den Pangaart, W. J.
Wiersinga, A. F. de Vos, S. Florquin, M. J. Bonten, and T. van der Poll.
2008. TLR2-dependent MyD88 signaling contributes to early host defense
in murine enterococcus faecium peritonitis. J Immunol '\80, no. 7: 486574.
Leinhardt, D. J., J. Arnold, K. A. Shipley, M. M. Mughal, R. A. Little, and M. H.
Irving. 1993. Plasma ne concentrations do not accurately reflect

144

sympathetic nervous system activity in human sepsis. Am J Physiol 265,
no. 2 Pt 1: E284-8.
Lesnyak, A. T, G. Sonnenfeld, M. P. Rykova, D. O. Meshkov, A. Mastro, and I.
Konstantinova. 1993. Immune changes in test animals during spaceflight.
J Leukoc Biol 54, no. 3: 214-26.
Leto, T. L. and M. Geiszt. 2006. Role of nox family nadph oxidases in host
defense. Antioxid Redox Signal 8, no. 9-10: 1549-61.
Linard, C., C. Marquette, J. Mathieu, A. Pennequin, D. Clarencon, and D. Mathe.
2004. Acute induction of inflammatory cytokine expression after gammairradiation in the rat: Effect of an nf-kappab inhibitor. IntJ Radiat Oncol
Biol Phys 58, no. 2: 427-34.
Liu, S. Z. 2004. Radiation-induced change in lymphocyte proliferation and its
neuroendocrine regulation: Dose-response relationship and
pathophysiological implications. Nonlinearity Biol Toxicol Med 2, no. 3:
233-43.
Locksley, R. M., N. Killeen, and M. J. Lenardo. 2001. The TNF and TNF receptor
superfamilies: Integrating mammalian biology. Ce//104, no. 4: 487-501.
Lorimore, S. A., P. J. Coates, G. E. Scobie, G. Milne, and E. G. Wright. 2001.
Inflammatory-type responses after exposure to ionizing radiation in vivo: A
mechanism for radiation-induced bystander effects? Oncogene 20, no. 48:
7085-95.
Lowry, R. H. 1961. Manned space exploration and the possibility of hypoxia. Can
Anaesth Soc J8: 70-5.
Lugade, A. A., E. W. Sorensen, S. A. Gerber, J. P. Moran, J. G. Frelinger, and E.
M. Lord. 2008. Radiation-induced IFN-gamma production within the tumor
microenvironment influences antitumor immunity. J ImmunoHSO, no. 5:
3132-9.
MacGregor, D. A., R. C. Prielipp, J. F. th Butterworth, R. L. James, and R. L.
Royster. 1996. Relative efficacy and potency of beta-adrenoceptor
agonists for generating camp in human lymphocytes. Chest ^09, no. 1:
194-200.
Mackay, I and F.S Rosen. 2000a. The immune system. New England Journal of
Med 343, no. 2: 9.
Mackay. 2000b. The immune system. Advances in Immunology 343, no. 1:12.
MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage
function. Annu Rev /mmuno/15: 323-50.

145

Madden, K. S., D. L. Bellinger, S. Y. Felten, E. Snyder, M. E. Maida, and D. L.
Felten. 1997. Alterations in sympathetic innervation of thymus and spleen
in aged mice. Mech Ageing Dev 94, no. 1-3: 165-75.
Maderna, P. and C. Godson. 2003. Phagocytosis of apoptotic cells and the
resolution of inflammation. Biochim Biophys Acta 1639, no. 3: 141-51.
Maimone, D., C. Cioni, S. Rosa, G. Macchia, F. Aloisi, and P. Annunziata. 1993.
Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by
astrocytes: Synergism with IL-1 beta and TNF alpha. J Neuroimmunol47,
no. 1:73-81.
Male, DK, J Brostoff, IM Roitt, and D Roth. 2006. Immunology.
Mandel, A. D. and E. Balish. 1977. Effect of space flight on cell-mediated
immunity. Aviat Space Environ Med 48, no. 11: 1051-7.
McCarthy, I. D. 2005. Fluid shifts due to microgravity and their effects on bone: A
review of current knowledge. Ann Biomed Eng 33, no. 1: 95-103.
McKinney, L.C, E.M Aquilla, D Coffin, D.A Wink, and Y Vodovotz. 1998. Ionizing
radiation potentiates the induction of nitric oxide synthase by IFN-gamma
and/or IPS in murine macrophage cell lines: Role of tnf-alpha. J Leukoc
Biol 64: 7.
Meehan, R., P. Whitson, and C. Sams. 1993. The role of psychoneuroendocrine
factors on spaceflight-induced immunological alterations. J Leukoc Biol
54, no. 3: 236-44.
Meistrell, M. E., 3rd, G. I. Botchkina, H. Wang, E. Di Santo, K. M. Cockroft, O.
Bloom, J. M. Vishnubhakat, P. Ghezzi, and K. J. Tracey. 1997. Tumor
necrosis factor is a brain damaging cytokine in cerebral ischemia. Shock
8, no. 5: 341-8.
Mignini, F., V. Streccioni, and F. Amenta. 2003. Autonomic innervation of
immune organs and neuroimmune modulation. Auton Autacoid Pharmacol
23, no. 1: 1-25.
Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001.
Interleukin-10 and the interleukin-10 receptor. Annu Rev ImmunoHd: 683765.
Nag, B., H. G. Wada, D. Passmore, B. R. Clark, S. D. Sharma, and H. M.
McConnell. 1993. Purified beta-chain of MHC class II binds to CD4
molecules on transfected HELA cells. J ImmunoHSO, no. 4: 1358-64.

146

Nash, P. V., I. V. Konstantinova, B. B. Fuchs, A. L. Rakhmilevich, A. T. Lesnyak,
and A. M. Mastro. 1992. Effect of spaceflight on lymphocyte proliferation
and interleukin-2 production. J Appl Physiol 73, no. 2 Suppl: 186S-190S.
Nash, P. V. and A. M. Mastro. 1992. Variable lymphocyte responses in rats after
space flight. Exp Cell Res 202, no. 1: 125-31.
Ogawa, Y, T Siabara, M Terashima, M Ono, N Hamada, A Nishioka, T Inomata,
S Onishi, S Yoshida, and H Seguchi. 1996. Sequential alteration of proto
oncogene expression in liver, spleen, kidney and brain of mice subjected
to whole body irradiation. . Oncology 53, no. 5: 4.
Oliveira, S. C., F. S. de Oliveira, G. C. Macedo, L. A. de Almeida, and N. B.
Carvalho. 2008. The role of innate immune receptors in the control of
brucella abortus infection: Toll-like receptors and beyond. Microbes Infect.
Olwell, P. M., D. C. Cottell, S. Ni Shuilleabhain, P. Maderna, C. Seymour, C.
Mothersill, and F. M. Lyng. 2005. Cytoskeletal reorganization and altered
phagocytotic ability in primary cultures of rainbow trout hemopoietic tissue
exposed to low-level ionizing radiation. Radiat Res 164, no. 1: 45-52.
Pandey, R, B.S Shankar, D Sharma, and K.B Sainis. 2005. Low dose radiation
induced immunomodulation: Effect on macrophages and CD8+1 cells. Intj
Radiat Biol QJ\: 11.
Pecaut, M. J., D. S. Gridley, and G. A. Nelson. 2003. Long-term effects of lowdose proton radiation on immunity in mice: Shielded vs. Unshielded. Aviat
Space Environ Med 74, no. 2: 115-24.
Pecaut, M. J., D. S. Gridley, A. L. Smith, and G. A. Nelson. 2002. Dose and dose
rate effects of whole-body proton-irradiation on lymphocyte blastogenesis
and hematological variables: Part II. Immunol Lett 80, no. 1: 67-73.
Pecaut, M. J., G. A. Nelson, and D. S. Gridley. 2001. Dose and dose rate effects
of whole-body gamma-irradiation: I. Lymphocytes and lymphoid organs. In
Vivo 15, no. 3: 195-208.
Pecaut, M. J., G. A. Nelson, L. L. Peters, P. J. Kostenuik, T. A. Bateman, S.
Morony, L. S. Stodieck, D. L. Lacey, S. J. Simske, and D. S. Gridley.
2003. Genetic models in applied physiology: Selected contribution: Effects
of spaceflight on immunity in the C57BL/6 mouse. I. Immune population
distributions. J Appl Physiol 94, no. 5: 2085-94.
Pecaut, M. J., S. J. Simske, and M. Fleshner. 2000. Spaceflight induces changes
in splenocyte subpopulations: Effectiveness of ground-based models. Am
J Physiol Regul Integr Comp Physiol 279, no. 6: R2072-8.

147

Pecaut, M. J., A. L. Smith, T. A. Jones, and D. S. Gridley. 2000. Modification of
immunologic and hematologic variables by method of C02 euthanasia.
Comp Med 50, no. 6: 595-602.
Pederson, B. A., C. R. Cope, J. M. Schroeder, M. W. Smith, J. M. Irimia, B. L.
Thurberg, A. A. DePaoli-Roach, and P. J. Roach. 2005. Exercise capacity
of mice genetically lacking muscle glycogen synthase: In mice, muscle
glycogen is not essential for exercise. J Biol Chem 280, no. 17: 17260-5.
Pierson, D. L, R. P. Stowe, T. M. Phillips, D. J. Lugg, and S. K. Mehta. 2005.
Epstein-barr virus shedding by astronauts during space flight. Brain Behav
Immun 19, no. 3: 235-42.
Pieters, J. 1997. MHC class II restricted antigen presentation. CurrOpin Immunol
9, no. 1: 89-96.
Pinner, R. W., S. M. Teutsch, L. Simonsen, L. A. Klug, J. M. Graber, M. J. Clarke
and R. L. Berkelman. 1996. Trends in infectious diseases mortality in the
united states. JAMA 275, no. 3: 189-93.
Poli, G., G. Leonarduzzi, F. Biasi, and E. Chiarpotto. 2004. Oxidative stress and
cell signalling. Curr Med Chem 11, no. 9: 1163-82.
Prisk, G. K., A. R. Elliott, and J. B. West. 2000. Sustained microgravity reduces
the human ventilatory response to hypoxia but not to hypercapnia. J Appl
Physiol 88, no. 4: 1421-30.
Rabot S., Szylit O., Nugon-Baudon L, Meslin JC., Vaissade P., Popot F., Viso M.
2000. Variations in digestive physiology of rats after short duration flights
aboard the US space shuttle. Digestive Diseases and Sciences 45, no. 9:
8.
Racine, R. N. and S. M. Cormier. 1992. Effect of spaceflight on rat hepatocytes:
A morphometric study. J Appl Physiol 73, no. 2 Suppl: 136S-141S.
Reilly, F. D., P. A. McCuskey, M. L. Miller, R. S. McCuskey, and H. A. Meineke.
1979. Innervation of the periarteriolar lymphatic sheath of the spleen.
Tissue Cell 11, no. 1: 121-6.
Reits, E. A., J. W. Hodge, C. A. Herberts, T. A. Groothuis, M. Chakraborty, E. K.
Wansley, K. Camphausen, R. M. Luiten, A. H. de Ru, J. Neijssen, A.
Griekspoor, E. Mesman, F. A. Verreck, H. Spits, J. Schlom, P. van Veelen,
and J. J. Neefjes. 2006. Radiation modulates the peptide repertoire,
enhances MHC class I expression, and induces successful antitumor
immunotherapy. J Exp Med 203, no. 5: 1259-71.

148

Ross, G. D. 2000. Regulation of the adhesion versus cytotoxic functions of the
MAC-1/CR3/alphambeta2-integrin glycoprotein. Crit Rev Immunol 20, no.
3: 197-222.
Rothwell, N. J. and G. N. Luheshi. 2000. Interleukin 1 in the brain: Biology,
pathology and therapeutic target. Trends Neurosci 23, no. 12: 618-25.
Sakihama, T., A. Smolyar, and E. L. Reinherz. 1995. Molecular recognition of
antigen involves lattice formation between CD4, MHC class II and ICR
molecules. Immunol Today'lO, no. 12: 581-7.
Sausen, K. P., E. A. Bower, M. E. Stiney, C. Feigl, R. Wartman, and J. B. Clark.
2003. A closed-loop reduced oxygen breathing device for inducing
hypoxia in humans. Aviat Space Environ Med 74, no. 11: 1190-7.
Schedlowski, Manfred and UweTewes. 1999. Psychoneuroimmunology: An
interdisciplinary introduction. New York: Kluwer Academic/Plenum
Publishers.
Schmid, D., J. Dengjel, O. Schoor, S. Stevanovic, and C. Munz. 2006. Autophagy
in innate and adaptive immunity against intracellular pathogens. J Mol
Med 84, no. 3: 194-202.
Schneider, H, Y.C. Cai, D Cefal, M Raab, and C.E Rudd. 1999. Mechanisms of
CD28 signaling.
Schorr, E. C. and B. G. Arnason. 1999. Interactions between the sympathetic
nervous system and the immune system. Brain Behav Immun 13, no. 4:
271-8.
Setlow, R. et al. 1996. Radiation hazards to crews of interplanetary missions:
Biological issues and research strategies. Washington, D.C.: National
Academy Press.
Seyle, H. 1998. A syndrome produced by diverse nocuous agents.
Neuropsychiatry Classics 10, no. 2: 1.
Shankar, B., S. Premachandran, S. D. Bharambe, P. Sundaresan, and K. B.
Sainis. 1999. Modification of immune response by low dose ionizing
radiation: Role of apoptosis. Immunol Lett 68, no. 2-3: 237-45.
Shechmeister, I. L. and M. Fishman. 1955. The effect of ionizing radiation on
phagocytosis and the bactericidal power of the blood. I. The effect of
radiation on migration of leucocytes. J Exp Med ^0^, no. 3: 259-74.
Silberman, D. M., M. Wald, and A. M. Genaro. 2002. Effects of chronic mild
stress on lymphocyte proliferative response. Participation of serum thyroid
hormones and corticosterone. Int Immunopharmacol 2, no. 4: 487-97.

149

Sonnenfeld, G. 1994. Effect of space flight on cytokine production. Acta
Astronaut 33: 143-7.
Sonnenfeld, G. 2005. The immune system in space, including earth-based
benefits of space-based research. Curr Pharm Biotechnol 6, no. 4: 343-9.
Sonnenfeld, G., M. Foster, D. Morton, F. Bailliard, N. A. Fowler, A. M.
Hakenewerth, R. Bates, and E. S. Miller, Jr. 1998. Spaceflight and
development of immune responses. J Appl Physiol 35, no. 4: 1429-33.
Sonnenfeld, G., Talor, G.R., Kinney, K.S. 2001a. Acute and chronic effects of
space flight on immune functions. Psyconeuroimmunology 2: 9.
Sonnenfeld, G., Taylor, G.R., Kinney, K.S. 2001b. Acute and chronic effects of
space flight on immune functions. Psychonueroimmunology 2: 9.
Staehelin, M., P. Muller, M. Portenier, and A. W. Harris. 1985. Beta-adrenergic
receptors and adenylate cyclase activity in murine lymphoid cell lines. J
Cyclic Nucleotide Protein Phosphor Res 10, no. 1: 55-64.
Stein, T. P. 2002. Space flight and oxidative stress. Nutrition 18, no. 10: 867-71.
Sternberg, E. M. 2006. Neural regulation of innate immunity: A coordinated
nonspecific host response to pathogens. Nat Rev Immunol 6, no. 4: 31828.
Stevens-Felten, S. Y. and D. L. Bellinger. 1997. Noradrenergic and peptidergic
innervation of lymphoid organs. Chem Immunol 69: 99-131.
Stojiljkovic, V., A. Todorovic, J. Kasapovic, S. Pejic, and S. B. Pajovic. 2005.
Antioxidant enzyme activity in rat hippocampus after chronic and acute
stress exposure. Ann N Y Acad Sc/1048: 373-6.
Stowe, R. P., D. L. Pierson, and A. D. Barrett. 2001. Elevated stress hormone
levels relate to epstein-barr virus reactivation in astronauts. Psychosom
Med 63, no. 6: 891-5.
Stulik, J, K Koupilova, L Hernychova, A Macela, V Blaha, C Baaske, W
Kaffenberger, and D van Beuningen. 1999. Modulation of signal
transduction pathways and global protein composition of macrophages by
ionizing radiation. Electrophoresis 20: 6.
Suttie, A. W. 2006. Histopathology of the spleen. Toxicol Pathol 34, no. 5: 466503.
Szelenyi, J., J. P. Kiss, and E. S. Vizi. 2000. Differential involvement of
sympathetic nervous system and immune system in the modulation of

150

TNF-alpha production by alpha2- and beta-adrenoceptors in mice. J
Neuroimmunol 103, no. 1: 34-40.
Szelenyi, J. and E. S. Vizi. 2007. The catecholamine cytokine balance:
Interaction between the brain and the immune system. Ann N Y Acad Sci
1113: 311-24.
Tabarean, I. V., H. Korn, and T. Bartfai. 2006. Interleukin-1 beta induces
hyperpolarization and modulates synaptic inhibition in preoptic and
anterior hypothalamic neurons. Neuroscience 141, no. 4: 1685-95.
Tamma, R., G. Colaianni, C. Camerino, A. Di Benedetto, G. Greco, M. Strippoli,
R. Vergari, A. Grano, L. Mancini, G. Mori, S. Colucci, M. Grano, and A.
Zallone. 2009. Microgravity during spaceflight directly affects in vitro
osteoclastogenesis and bone resorption. FASEB J.
Tan, K. S., A. G. Nackley, K. Satterfield, W. Maixner, L. Diatchenko, and P. M.
Flood. 2007. Beta2 adrenergic receptor activation stimulates proinflammatory cytokine production in macrophages via PKA- and NF-kappa
B-independent mechanisms. Cell SignaHd, no. 2: 251-60.
Taylor, G. R. and R. P. Janney. 1992. In vivo testing confirms a blunting of the
human cell-mediated immune mechanism during space flight. J Leukoc
Biol 51, no. 2: 129-32.
Taylor, G. R., L. S. Neale, and J. R. Dardano. 1986. Immunological analyses of
US. Space shuttle crewmembers. Aviat Space Environ Med 57, no. 3:
213-7.
Taylor, P. W. and A. P. Sommer. 2005. Towards rational treatment of bacterial
infections during extended space travel. Int J Antimicrob Agents 26, no. 3:
183-7.
Tipton, C. M., J. E. Greenleaf, and C. G. Jackson. 1996. Neuroendocrine and
immune system responses with spaceflights. Med Sci Sports Exerc 28.
no. 8: 988-98.
Townsend, L. W. 2005. Implications of the space radiation environment for
human exploration in deep space. Radiat Prot Dosimetry 115, no. 1-4: 4450.
Townsend, L. W. 2007. Space exploration and the ‘universe’-al problem of
ionizing radiation.
Turner, C, H.M Bilgin, B.D Obay, H Diken, E Tasdemir, and A Atmaca. 2005.
Macrophage phagocytic activity at acute cold-restraint stress exposed
rats: Possible role of nitric oxide. Biotechnol. & Biotechnol. 19, no. 3: 6.

151

Ullrich, O., K. Huber, and K. Lang. 2008. Signal transduction in cells of the
immune system in microgravity. Cell Commun Signal 6: 9.
Underhill, D. M. and A. Ozinsky. 2002. Phagocytosis of microbes: Complexity in
action. Annu Rev Immunol 20: 825-52.
van der Laan, L. J., E. A. Dopp, R. Haworth, T. Pikkarainen, M. Kangas, O.
Elomaa, C. D. Dijkstra, S. Gordon, K. Tryggvason, and G. Kraal. 1999.
Regulation and functional involvement of macrophage scavenger receptor
marco in clearance of bacteria in vivo. J /mmuno/162, no. 2: 939-47.
Wan, C. P., E. Myung, and B. H. Lau. 1993. An automated micro-fluorometric
assay for monitoring oxidative burst activity of phagocytes. J Immunol
Meth 159, no. 1-2: 131-8.
Wang, K. X., Y. Shi, and D. T. Denhardt. 2007. Osteopontin regulates hindlimbunloading-induced lymphoid organ atrophy and weight loss by modulating
corticosteroid production. Proc Natl Acad Sci USA 104, no. 37: 1477782.
Warren, J. S. 1990. Interleukins and tumor necrosis factor in inflammation. Crit
Rev Clin Lab Sci 28, no. 1: 37-59.
Watkins, L. R., L. E. Goehler, J. Relton, M. T. Brewer, and S. F. Maier. 1995.
Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia.
Brain Res 692, no. 1-2: 244-50.
Weenink, S. M. and A. M. Gautam. 1997. Antigen presentation by MHC class II
molecules. Immunol Cell Biol 75, no. 1: 69-81.
Williams, J. M. and D. L. Felten. 1981. Sympathetic innervation of murine thymus
and spleen: A comparative histofluorescence study. Anat Rec 199, no. 4:
531-42.
Williams, L. T, R. Snyderman, and R. J. Lefkowitz. 1976. Identification of betaadrenergic receptors in human lymphocytes by (-) (3h) alprenolol binding.
J Clin Invests?, no. 1: 149-55.
Xapsos, MA, C Stauffer, JL Barth, and EA Burke. 2006. Solar particle events and
self-organized criticallity: Are deterministic predictions of events possible?
Nuclear Science 53, no. 4: 1839-1843.
Xing, Z, J Gauldie, G Cox, H Baumann, M Jordana, X Lei, and M.K Achong.
1998. IL-6 is an antiinflammatory cytokine required for controlling local or
systemic acute inflammatory responses. J Clin. Invest. 101, no. 2: 9.

152

